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The aim of this thesis was to develop new X-ray and neutron scattering techniques
to investigate amyloid fibrils. Specifically, the development of techniques which can
probe kinetic and structural information that can be difficult to obtain using current
techniques.
Lysozyme seeded aggregation kinetics was investigated at high concentrations and gave
unexpected results for the dependence of initial elongation rate on monomer concen-
tration. Briefly, a combined small angle and wide angle X-ray scattering technique was
probed as a label-free method to follow lysozyme aggregation kinetics under shear.
A novel contrast-matched small-angle neutron scattering technique was developed which
gave kinetic elongation rates for the peptide NFGAIL and the protein α-synuclein
of 1.9± 0.1 nm min−1 and 0.66± 0.09 nm min−1, respectively. In addition, the tech-
nique gave a new method for estimating fibril seed lengths, which were estimated to
be 91± 20 nm and 1900± 600 nm, for NFGAIL and α-synuclein, respectively. Fur-
thermore, this technique was sensitive to secondary kinetic pathways and reported no
significant contribution to the kinetics from secondary pathways.
Development of a neutron fibre diffraction technique utilising isotope-labelling allowed
insight into the structural packing within TTR (105–115) fibrils. In conjunction with
fibre diffraction simulations, this approach concluded the steric zipper packing within
the TTR (105–115) fibrils to be that of steric zipper 3 (Parallel, face-to-face, up-down).
These techniques provided extensive information on the structure and kinetics of amy-
loid fibrils. The methods can be employed under physiological conditions and may be
useful in the study of the prevention and inhibition of amyloid aggregation.
Abbreviations
HEWL Hen Egg White Lysozyme
SAXS Small Angle X-ray Scattering
WAXS Wide Angle X-ray Scattering
SANS Small Angle Neutron Scattering
TEM Transmission Electron Microscopy
ThT Thioflavin T
MPUL Mass Per Unit Length
AFM Atomic Force Microscopy
dSTORM direct Stochastic Optical Reconstruction Microscopy
SLD Scattering Length Density
NMR Nuclear Magnetic Resonance
cryo-EM cryo-Electron Microscopy
STEM Scanning Transmission Electron Microscopy
DMSO Dimethyl Sulfoxide
TFA Trif luoroacetic Acid
ILL Institut Laue–Langevin
TTR Transthyretin
HPCE High-Performance Capillary Electrophoresis




The project undertaken was a joint PhD between the ISIS neutron facility at the Ruther-
ford Appleton Laboratory in Oxfordshire, and the Department of Chemistry at the Uni-
versity of Bath. We aimed to develop new X-ray and neutron scattering approaches
centred on a novel isotope labelling approach. We applied these techniques we developed
to examine amyloid protein fibrils which are linked with diseases such as Alzheimer’s
and prion disorders. By utilizing a unique combination of techniques we planned to be
able to acquire information that is otherwise unobtainable, such as the dynamics of fibril
growth and breakage, and molecular organisation within fibrils. We set out to use these
processes to calculate elongation rates of fibrils and to allow accurate determination of
precise structures which could be used in the development of materials, from nanotubes
to proteins and polymers.
1.1 Amyloid Fibrils
The term amyloid can be traced back to 1854 when it was introduced by Rudolph
Virchow, a German physician scientist [1]. Virchow discovered that when he used
Congo red staining on a macroscopic tissue abnormality from the coporea amylacea of
the nervous system, the result was similar to that of when Congo red staining is used
on cellulose and starch [2]. Thus he called the substance “amyloid”, meaning “starch-
like”. It was not until much later that these substances were shown to consist of protein
through the use of chemical analysis. Friederich and Kekule determined that protein
was present due to the high nitrogen content of these substances, which disproved them
as carbohydrate based [1]. However, as the name amyloid had been well established,
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the term was still used and is still in use today. The name has remained even though
amyloids do not contain any starch at all.
Amyloid fibrils are formed when proteins and peptides that are usually soluble, self-
associate to form insoluble fibres that do not readily degrade [3]. When this self-
association occurs within the body, it can be associated with disease and tissue damage
[4]. A list of some of the diseases associated with amyloid fibril formation is shown in
Table 1.1 [5].
Table 1.1: A selection of diseases associated with amyloid fibril formation.
Disease Aggregating Protein/Peptide
Alzheimer’s disease Amyloid-β peptide & tau
Parkinson’s disease α-synuclein
Huntington’s disease Huntingtin fragments (polyQ)
Type II diabetes IAPP
Senile systemic amyloidosis Wild-type transthyretin
Spongiform encephalopathies Prion protein
Lysozyme amyloidosis Lysozyme
Research into this area has increased markedly in recent years due to the realisation
that amyloid fibril associated diseases are rapidly becoming the most common and
debilitating diseases in the modern world [6]. Therefore, there has been huge interest
in research that can inhibit the formation of amyloid fibril formation, and research to
understand the underlying mechanisms and kinetics of fibril formation [7, 8].
1.1.1 Fibril Structure
Amyloid fibrils are often found to be micrometres in length but only a few nanometres
in diameter. Probing of these fibrils often reveals that the fibril structure is actu-
ally made of several smaller protofilaments, which wrap around each other to form a
rope-like structure [9]. Further investigation reveals that the fibrils have a “cross-β”
structure. Within the protofilament structure there is a polypeptide chain which is or-
ganised into β-sheets which are parallel to the fibril axis with the constituent β-strands
perpendicular to the fibril axis (Figure 1.1). Due to the preferred right-handed nature
of β-sheets there is also often a helical structure observed [10].
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Figure 1.1: Hierarchy of substructures present in the self-assembly of amyloid fibrils
(Reproduced from reference [11]).
Recent studies utilising X-ray and electron diffraction, solid-state nuclear magnetic res-
onance (NMR), cryo-electron microscopy (cryo-EM), or a combination of these tech-
niques have provided atomic-resolution structures of amyloid fibrils [12–14]. X-ray and
electron diffraction require well-ordered crystals to determine amyloid structures but
due to the twisted nature of amyloid fibrils they do not readily form crystals. However,
some short peptides have been shown to form both amyloid-like crystals and amyloid
fibrils [15]. The short peptides that are investigated are often segments of disease-
related amyloid-forming proteins. As the peptides are often only a few residues in
length, the crystal structure may give some information on the spine structure of a
polymorph related to fibrils formed by the full protein, but does not reveal information
on the structure outside of the amyloid spine.
To determine structural models of amyloid fibrils using solid-state NMR requires fibrils
formed from proteins/peptides that contain amino acids which have been isotopically la-
belled [16]. From the resonances recorded for the isotope-labelled fibrils, constraints on
the parallel/anti-parallel packing, inter-residue contacts of the amino acid side chains,
and the overall arrangement of the cross-β structure can be determined. These con-
straints can then be used to develop a molecular structural model for the fibrils. Most
of the constraints determined from solid-state NMR are not currently possible to de-
termine using other techniques. Three polymorphs of Aβ(1–40) fibrils determined by
solid-state NMR are shown in Figure 1.2 [17–19].
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Figure 1.2: Models of three polymorphs of Aβ(1–40) fibrils determined by solid-state
nuclear magnetic resonance. Shown at the top is a view down the protofilament axis
and a tilted view showing six layers of the protofilament is shown below. (a) Striated
ribbon polymorph. (b) Polymorph showing a 3-fold axis of symmetry. (c) Polymorph
formed from Aβ(1–40) with the Osaka mutation (Reprinted with permission from
[20]).
Advancements in cryo-EM has allowed near-atomic resolution structures of a variety of
amyloid fibrils without the need for crystals or isotope-labelling [21]. With a suitable
number of well-ordered samples, cryo-EM can determine the atomic structure of the
fibrils, the degree of twist in the fibrils and the number of protofilaments present.
Recently, through the use of cryo-EM helical reconstruction, Li et al reported structures
of two polymorph fibrils formed from full-length recombinant human α-synuclein at a
resolution of 3.7A [22]. The polymorphs were shown to share a kernel structure of a
bent β-arch but had different inter-protofilament interfaces. The cryo-EM structure
and models of the α-synuclein polymorphs are shown in Figure 1.3.
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Figure 1.3: Cryogenic electron microscopy structure and atomic models of two poly-
morphs of full-length recombinant human α-synuclein fibrils. Density slices of the rod
(left) and twister (right) polymorphs from the cryo-EM structures are shown (top).
Atomic models showing a section of the fibrils at different angles are displayed below
the cryo-EM structures. On either side of the atomic models there is a 3D model of
the rod (blue) and twister (red) polymorphs, showing their helical repeats (Reprinted
from [22] under the terms and conditions of the Creative Commons Attribution (CC
BY) license (http://creativecommons.org/licenses/by/4.0/).
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1.1.2 Fibril Kinetics
Research has shown that fibril formation is a multi-step process, in which during the
early prefibrillar stages, there are small protein multimers which can disassemble or be
consumed as fibrillation proceeds. A general idea surrounding the driving force of fibril
formation from proteins is the destabilisation of the protein’s native state to form a
partially unfolded state which then favours aggregation. These small aggregations of
partially unfolded protein can then associate to form longer fibrillar aggregates, which
are known as protofilaments. Finally, these protofilaments can then associate to form
amyloid fibril structures. An overview of the aggregation scheme for amyloid fibrils is
shown in Figure 1.4 [23].
Figure 1.4: Amyloid fibril aggregation scheme. (Reprinted from Journal of Molecular
Biology, 381, J. T. Giurleo, X. He, D. S. Talaga, β-Lactoglobulin Assembles into
Amyloid through Sequential Aggregated Intermediates, 1332–1348, Copyright (2008),
with permission from Elsevier.) [23]
The first area we are looking to investigate within the project is that relating to the
dynamics of fibril growth and fibril elongation rates. Previously, there have been many
studies related to initial fibril formation, where a peptide or protein solution will ag-
gregate to form initial aggregates which then form fibrils [24, 25]. These studies have
shown that amyloid fibril formation generally occurs via a self-assembly nucleation re-
action that can be described by sigmoidal growth kinetics [26]. Generally, there are
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three phases to the kinetics of amyloid fibril growth, a lag phase, a growth phase and
a plateau phase. A typical plot of aggregate concentration versus time for amyloid
fibril formation would show an almost flat initial area (lag phase), followed by a steep
increase (growth phase), and then finally another flat region (plateau phase) where the
monomer concentration has reached an equilibrium value (Figure 1.5) [27]. Arosio and
colleagues have stated that the lag phase is not a time period in which we are waiting
for the formation of amyloid nuclei, but instead there are many processes occurring in
parallel, with many different nuclei forming in the initial lag phase [26]. Therefore, the
lag phase can be described as a period of time which is needed for the initial nuclei
formed to grow and their concentration increase, so that the concentration of aggregates
is high enough to be detected by bulk spectroscopic techniques.
Figure 1.5: Sigmoidal growth profile of fibril mass formation (Reprinted from refer-
ence [28] under the terms and conditions of the Creative Commons Attribution (CC
BY) license (http://creativecommons.org/licenses/by/4.0/)).
However, the work in this thesis focuses on the study of “seeded” amyloid fibril growth.
The addition of preformed fibril seeds of the same peptide or protein to the monomeric
solution leads to the acceleration of fibril growth and removes the “lag-phase” that
is apparent in unseeded amyloid fibril growth [29]. In this report a monomer will
correspond to a single peptide chain or protein. The fibril seeds remove the need for
aggregation and nucleation before fibril elongation, as the monomeric protein or peptide
in solution can add to the ends of the fibril seeds. By determining the kinetics of this
seeded amyloid fibril growth and how it can be inhibited by certain species, a model
could be produced for other proteins or prions that would allow determination of how
amyloid fibrils propagate and how amyloid diseases can be prevented.
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1.1.3 Biological and Disease Relevance of Amyloids
It has been confirmed that there are at least 50 different amyloid fibril forming proteins
or peptides which are associated with human disease [30]. The proteins or peptides
aggregate into amyloid fibrils which deposit into extracelluar plaques and intracellular
inclusions which are associated with disease. This process is strongly linked to ageing
[31]. These diseases can be broadly split into two main classes: degenerative and prion.
An example of a degenerative disease is Alzheimer’s disease, whilst an example of a
prion disease is Creutzfeldt-Jakob disease [32]. Prions are a subset of amyloid that are
infectious and can seed amyloid fibril formation in vivo in other systems [33].
Alzheimer’s disease is considered the most prevalent progressive neurodegenerative dis-
order and is one of the most common causes of death in the developed world [34]. The
causes and pathology of Alzheimer’s disease are not entirely understood, but an exten-
sive amount of information suggests that Aβ oligomers are the main culprit [35–37].
Aggregation of human lysozyme within the body is associated with the disease, lysozyme
amyloidosis. It is a disorder where aggregation of lysozyme and deposition in ex-
traceullar plaques leads to disruption of organ structure and function, eventually caus-
ing multi-organ failure [38].
Amyloid deposits within the body mainly consist of amyloid fibrils. However, they
can also contain many non-fibrillar components. Typically, these components are not
dependent on the precursor protein, from which the fibrils are formed [39]. The de-
posits can contain apoliprotein E, protein serum amyloid P component, proteoglycans
and glycosaminoglycans [40–43]. It has been indicated that glycosaminoglycans can
favour and stabilise amyloid fibril formation [43]. The glycosaminoglycans which have
negative polyelectrolyte charges, and the aggregating proteins which have positively
charged side chain residues, bind through electrostatic interactions. The glycosamino-
glycans act as a structural template for the aggregation of toxic oligomers into amyloid
fibrils, suggesting they could possibly be used for therapy in amyloidosis [44]. In this
thesis, unlike the amyloid deposits in vivo, the experiments focus on the aggregation
of amyloidogenic proteins in the absence of these additional non-fibrillar components.
Although amyloid fibrils have been historically associated with disease, many studies
have reported amyloids which have a functional use [45]. These amyloids have been
termed ‘functional amyloids’ and have been associated with normal physiological func-
tions in living organisms. These functional amyloids have been shown to be involved
with epigenetic control of polyamines, regulation of melanin synthesis, information
transfer, biofilm formation, scaffolding, and development of aerial structures [46]. It
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appears that organisms have evolved to utilise the amyloid β-sheet structure which has
self-seeding properties, high resistance to proteolysis and the ability to function as a
molecular memory. Functional amyloids are not toxic to their host and an understand-
ing of how functional amyloids are generated without toxicity may yield knowledge that
could help prevent amyloid toxicity in amyloidosis [28]. However, recent studies have
shown that the functional amyloid production of bacteria found within humans can
expose the human body to high systemic amyloid burden. A main secretory product
of microbes is amyloid and this microbial amyloid may substantially contribute to the
pathophysiology of the human central nervous system [47].
1.1.4 Outline of Thesis
This thesis presents the use of novel X-ray and neutron scattering techniques to inves-
tigate amyloid fibril structure and kinetics. First, in Chapter 4 the seeded aggregation
of lysozyme at high monomer concentration is probed and then X-ray scattering is
used to follow seeded lysozyme aggregation kinetics under shear. Second, in Chapters
5 and 6 a contrast matched small angle neutron scattering (SANS) technique is used
to determine elongation rates, presence of secondary pathways and average initial seed
lengths for amyloid fibril kinetics of the peptide NFGAIL and the protein α-synuclein.
Finally, a neutron fibre diffraction technique utilising an isotope-labelling scheme and
simulation of amyloid neutron diffraction patterns was exploited to investigate struc-
tural packing within YTIAALLSPYS fibrils. Further details of background and context




This section provides a brief background to the systems studied and techniques used
within this work.
2.1 Proteins and Peptides Studied
2.1.1 Lysozyme
Hen-egg white lysozyme (HEWL) is a small, 129-residue protein (14.3 kDa) that has
been extensively studied to understand protein folding, misfolding and amyloid for-
mation [48, 49]. HEWL is highly homologous to human lysozyme and investigat-
ing lysozyme aggregation may have therapeutic benefits for treating amyloidosis [50].
HEWL is often used as a model protein for investigating amyloid aggregation due to
the wealth of information available regarding its structure and folding properties [51].
HEWL has been aggregated under a multitude of conditions leading to different ag-
gregation pathways [52–58]. Investigations using HEWL as a model protein may allow
determination of structural and mechanistic principles that could be applied in general
to amyloid fibrils. HEWL was chosen for this work as it is a model protein for amyloid
formation and was cost-effective for the large quantities of protein required for the high
concentration beamline experiments.
2.1.2 NFGAIL
NFGAIL is a hexapeptide fragment (residues 22-27) of the human islet amyloid polypep-
tide (hIAPP) [59]. Aggregation of hIAPP leads to the formation of pancreatic amyloid
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which has been found to be present in over 95% of type 2 diabetes patients [60]. hI-
APP fibrils are cytotoxic and are believed to be linked with the development of Type 2
diabetes [61]. NFGAIL forms fibrils with cytotoxicity and structure analogous to those
formed by hIAPP, making NFGAIL a model system for investigating amyloid forma-
tion [62]. NFGAIL was chosen as the initial system to investigate as we developed a
contrast matched SANS technique due to the hypothesis that a short peptide system
would reduce the complexity of the SANS modelling.
2.1.3 α-Synuclein
α-Synuclein is a 140-residue soluble brain protein that is natively unfolded (intrinsically
unstructured) [63]. Studies into the functional and structural roles of α-Synuclein have
shown that it plays a role in synaptic vesicle transport and the regulation of neuro-
transmitter release [64]. Aggregation of α-Synuclein is implicated as a key step in the
development of Parkinson’s disease [65]. Mutations, genetic duplication and a reduc-
tion in clearance, as well as amplified expression, can lead to increased accumulation of
α-Synuclein which is associated with Parkinson’s disease and related synucleinopathies
[66]. The structure of micelle-bound human α-Synuclein is shown in Figure 2.1.
Figure 2.1: The structure of micelle-bound human α-Synuclein. Point muta-
tions which are associated with Parkinson’s disease are labelled and shown in pink.
(Reprinted from [67] under the terms of the Creative Commons Zero ”No rights re-
served” data waiver (CC0 1.0 Public domain dedication).
The protein has a lysine rich, amphipathic N-terminal region, a flexible, disordered,
negatively charged C-terminal tail and a central motif known as the non-amyloid-β
component of Alzheimer’s disease amyloid plaques which is strongly hydrophobic. The
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removal of parts within this central motif greatly reduces the aggregation propensity
of the protein. One of the hallmarks of Parkinson’s disease is the presence of intra-
cellular inclusions (Lewy bodies), of which α-Synuclein is the main constituent [68].
Therapeutic strategies to combat Parkinson’s disease could include the reduction of
α-Synuclein expression or aggregation and preventing accumulation of α-Synuclein by
improving protein clearance [69]. Once the contrast matched SANS technique in this
work gave results for a short peptide (NFGAIL), α-Synuclein was chosen as a more
complex protein model to further test the developed technique.
2.1.4 TTR(105-115) (YTIAALLSPYS)
TTR(105-115) is an eleven residue peptide fragment corresponding to β-strand G of
human transthyretin (TTR) [70]. TTR is a 55 kDa homotetramer transport protein
responsible for transporting thyroxine and retinol [71]. Dissociation of the tetramer
into monomers can lead to aggregation of TTR into amyloid fibrils [72]. Formation of
these fibrils in vivo is associated with diseases such as senile systemic amyloidosis [73],
familial amyloidotic polyneuropathy [74], and familial amyloidotic cardiomyopathy [75].
TTR(105-115) forms amyloid fibrils in vitro and is an ideal model system for testing
new structural techniques as the atomic resolution structure of TTR(105-115) fibrils
has been previously reported [11, 76, 77].
2.2 X-ray and Neutron Scattering Techniques
2.2.1 Small Angle X-ray Scattering and Small Angle Neutron Scat-
tering
Small angle X-ray scattering (SAXS) and SANS are techniques which can be used to
probe structures from approximately 1 to 100 nm. Scattering is a process whereby a
beam of radiation or particles is deviated from its initial trajectory by the inhomo-
geneities in the medium which it traverses [78]. For structural studies, where informa-
tion such as size, shape and orientation of components in a system are investigated,
elastic scattering effects are exploited. The basic equations and methods used for SANS
and SAXS are similar, with differences arising from how each radiation interacts with
the scattering medium. X-rays interact with the electrons of the atoms within a sample,
whereas neutrons interact with the nuclei of the atoms within a sample.
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Elastic scattering is due to interference of waves emitted by the individual scatterers
within the coherently scattering volume, where the scatterers have correlated positions
in space [78]. The direction of the scattered waves is dependent on the relative positions
of those scatterers, whether they be individual atoms or planes of atoms (as in diffrac-
tion) or ensembles of atoms or molecules (as in scattering) and therefore structural
information regarding the sample being investigated can be obtained. A schematic
diagram of a SAXS or SANS experiment is depicted in Figure 2.2. In a small angle
scattering experiment, neutrons or X-rays with wavelength λ and wave vector kˆo, with
magnitude 2piλ , interact with the sample, resulting in a scattered wave vector kˆf with
scattering angle 2θ [79]. As depicted in Figure 2.2, the momentum transfer qˆ can be










A 2D detector measures the scattered intensity and gives a 2D pattern arising from the
sample. In systems where there is not a preferred orientation of the molecules, the 2D
pattern can be radially averaged to give a 1D pattern of the intensity as a function of
q [79].
Figure 2.2: A schematic diagram depicting a SANS or SAXS experiment (Reprinted
from [79] under the terms and conditions of the Creative Commons Attribution (CC
BY) license (http://creativecommons.org/licenses/by/4.0/)).
There is, therefore, an inverse relationship between the size of the objects that scatter
the radiation and the angle at which the radiation is scattered (Equation 2.2). At low
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q larger dimensions are probed and at high q smaller dimensions are probed. At larger
angles, such as in wide angle X-ray scattering (WAXS) experiments which are discussed
later in this chapter, sub-nanometre dimensions can be probed [80].
2.2.1.1 Forward Scattering Intensity
The small angle neutron and X-ray scattering experiments in this work take advantage
of two parameters, the forward scattering intensity I(0), and the forward scattering
intensity of the cross-section Ic(0).
For a small angle scattering experiment probing a solution of monodisperse, randomly
orientated particles, the intensity can be given as





where ∆ρ is the contrast, n is the number density of particles, V is the particle volume
and |F (qˆ)|2 is the scattering form factor, which is a mathematical expression of the
shape of the scattering entity [81].
The contrast, ∆ρ, is given as
∆ρ = ρp − ρs, (2.4)
where ρp and ρs are the scattering length densities of the particles and the solvent,
respectively.
For the condition, q = 0 , a model-independent parameter can be obtained, I(0), which
is referred to as the forward scattering intensity. When q = 0 and |F (qˆ)|2 = 1 , I(0)
can be given as
I (0) = n (∆ρ)2 V 2. (2.5)
The value of I(0) can be determined by plotting a Guinier plot of ln(I(q)) versus q2,
utilising the Guinier approximation [82],
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where Rg is the radius of gyration, a parameter that gives information on particle
size. The Guinier approximation is typically valid for monodisperse, non-interacting
particles in the range qRg < 1.3.
The natural log of the approximation gives rise to the resulting Guinier plot,




whereby the value of I(0) can be determined from the intercept of a linear fit at low q.
For elongated particles this approximation is valid in the region where qRg . 1.5.
The second parameter, the forward scattering intensity of the cross-section Ic(0) is












The y-intercept of the plot is Ic(0). By determining the forward scattering intensity of




piC(ρp − ρs)2 , (2.9)
where d is the mean density of a protein (1.35 g ml−1), NA is Avogadro’s number
(6.022× 1023 mol−1), C is the concentration of peptide/protein in the fibril seeds, ρp
is the scattering length density of the fibrils and ρs is the scattering length density of
the solvent.
The use of Ic(0) becomes important when the length of the fibrils being examined
exceeds the length that can be measured by the small angle neutron or X-ray scattering
experiment. Under these conditions, only the two-dimensional cross section of the fibril
is being probed and the previous Guinier analysis breaks down.
2.2.2 Fibre Diffraction and Wide Angle X-ray Scattering
As has been explained above, small angle scattering allows us to determine the shape,
size and orientation of molecules and ensembles on the scale of 1-100 nm and their
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molecular weight. However, to determine how the molecules and atoms arrange within
the fibrils, diffraction techniques to determine the crystalline structure are required.
X-ray fibre diffraction is a technique commonly used to determine the presence of amy-
loid fibrils [84]. X-ray diffraction and WAXS are often treated as identical techniques in
the literature as they cover the same q range [85]. The difference in terms arising from
whether the sample being investigated is crystalline (diffraction) or not (WAXS). In
addition to being a simple tool for amyloid detection, fibre diffraction experiments al-
low investigation of amyloid fibril structure [86]. Due to the insoluble and polydisperse
nature of fibrils, techniques previously used to determine high resolution structures of
proteins such as solution-phase NMR and X-ray crystallography are not very effective
[87].
Fibre diffraction experiments of amyloid fibrils produce a characteristic cross-β pattern
(Figure 2.3) [88]. The first neutron fibre diffraction studies of an amyloid system were
reported by Tiggelaar et al. in 2011 [89]. Reflections measured from high resolution




Figure 2.3: Schematic diagram of a fibre diffraction experiment. When a partially
aligned sample of amyloid fibrils is exposed to X-rays or neutrons a characteristic cross-
β diffraction pattern is produced. The reflections at 4.7 and ∼10A correspond to the
inter-strand and inter-sheet spacing of the cross-β structure, respectively (Adapted by
permission from Springer Nature Customer Service Centre GmbH: Springer Nature,
Journal of Chemical Biology, Binding mode of Thioflavin T and other molecular probes
in the context of amyloid fibrils—current status, Groenning, M. (2010) [90]).
2.2.3 Contrast Matching
Although neutron scattering and X-ray scattering are both scattering techniques that
provide structural information, neutrons and X-rays interact with matter differently.
This difference in interaction provides additional methods to probe structure and to
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investigate systems. The scattering of X-rays by an atom is dependent on the electron
charge density of the atom. X-rays interact more strongly with atoms with a larger
atomic number due to the increased number of electrons. In contrast to X-rays, neu-
trons interact with the nucleus of an atom rather than the electron cloud. There is no
regular difference of scattering arising from atomic number for neutrons, as is present
for X-rays [91]. The scattering power (cross section) of elements therefore varies be-
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Figure 2.4: Scattering cross sections for various elements (Adapted from [79] un-
der the terms and conditions of the Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/)) [92, 93].
As the interaction of a neutron with an atom is nucleus dependent and not electron
cloud dependent, isotopes of the same element have vastly different scattering lengths
(Table 2.1). This is important as it means that SANS experiments are sensitive to
isotopic substitution. The intensity of scattering measured for a system will depend
on the difference in scattering length densities between the solvent and the particles
under investigation. The most significant isotopic variation and the one that we will
exploit in this work is that of hydrogen and deuterium. The coherent scattering length
of hydrogen is negative (−0.374× 10−12 cm) whilst the scattering length of deuterium
is strongly positive (0.667× 10−12 cm). As water is the solvent for most biological
experiments and is indeed the solvent for the amyloid fibril experiments within this
thesis, this allows for a variation in the scattering length density of the solvent between
−0.562× 1010 cm−2 for pure H2O and 6.356× 1010 cm−2 for pure D2O, by varying the
fraction of H2O and D2O in the solvent. The entirety of this range should include
the scattering length densities related to the hydrogenated peptides/proteins and the
amyloid fibrils they form, that are used in this thesis (Figure 2.5).
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Table 2.1: Neutron coherent scattering length, b, for various nuclei. [78]
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Figure 2.5: Neutron scattering length densities versus D2O fraction of the sol-
vent for hydrogenated and perdeuterated biological molecules. The H2O/D2O
contrast match conditions are marked by an arrow (Reprinted from [79] under
the terms and conditions of the Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/)).
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Therefore, in SANS experiments the neutrons can “see” hydrogen isotopes and it is
possible to differentiate between them. It can be deduced that if a component of the
system under investigation has the same scattering length density as the solvent, then
the average contrast is zero and this is known as the contrast match point. For a two
component system (Figure 2.6), one of the components can be contrast matched to the
solvent to allow probing of the other unmatched component.
Multiple components
Contrast Match Point for 
Component A
Contrast Match Point for
 Component B
Figure 2.6: A schematic diagram depicting contrast matching. Component A is
shown in blue, whilst Component B is shown in purple.
In addition to varying the H2O/D2O content of the solvent, selective deuteration of a
component for instance in biological molecules, allows for structural probing of a specific
region. Exchanging hydrogen for deuterium in the solvent or molecule, is expected to
have little effect on molecular shape or interactions [78].
2.3 Transmission Electron Microscopy
It is important to verify the lengths and average diameter determined by SAXS and
SANS by additional techniques. In this work we used transmission electron microscopy
(TEM). TEM is a technique allowing both qualitative and quantitative investigations
of amyloid fibrils. By negatively staining fibrils, using a dye such as uranyl acetate,
TEM allows visualisation of fibril structure and morphology [94]. Additionally, it can
allow for visualisation of other amyloidogenic species such as protofilaments and early
aggregates [95]. Due to TEM being a high resolution imaging technique, features such
as multiple protofilaments, fibril twisting, flat tape-like morphology and fibril curvature
can be detected [96]. Also, fibrillar structural dimensions such as fibril width, length
and periodicity can be measured. TEM is not however, able to detect the presence of
cross-β structure, so additional techniques such as X-ray fibre diffraction are required
to determine if the species imaged are amyloid fibrils or aggregates with fibre-like
33
Background 2.4. Thioflavin T Fluorescence Assay
morphology. Additionally, a drawback of TEM is that it requires extensive sample
preparation. Unlike SAXS and SANS it cannot be used for real-time measurements in
solution. It is therefore unsuitable for following growth rates of amyloid kinetics.
2.4 Thioflavin T Fluorescence Assay
In contrast to TEM, ThT is commonly used to follow amyloid fibril kinetics. ThT is
a benzothiazole dye that was first used as a fluorescent probe to detect amyloid fibrils
in 1959 [97]. The structure of ThT is shown in Figure 2.7. ThT fluorescence is often





Figure 2.7: The structure of Thioflavin T.
The C-C bond linking the benzothiazole group to the N,N-dimethylaniline region al-
lows for rotation of the molecule in aqueous solutions (Figure 2.8a) [99]. Through this
rotation the molecule has a non-emissive decay pathway for the excited state generated
by photon excitation [100]. Upon binding to amyloid fibrils there is a shift of the exci-
tation maximum (from 350 nm to approximately 440 nm) and the emission maximum
(from 440 nm to approximately 490 nm), and a substantial increase in the emission
intensity (Figure 2.8b). It is suggested that rotational immobilization of ThT caused
by ThT-Fibril binding causes this increased emission due to preservation of the excited
state [101]. ThT is believed to bind to amyloid fibrils in a ‘channel’ mode (Figure 2.8c).
The cross-β structure of amyloid fibrils contains β-strands with regularly packed side
chains which form a channel-like structure that runs parallel to the fibril axis. On the
surface of fibrils these ‘channels’ are solvent-exposed and ThT could bind within these
‘channels’ [102].
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Figure 2.8: Emission and binding of ThT. (a) Rotation of ThT around the C-
C bond quenches excited states leading to low emission. (b) Increase in emis-
sion intensity of ThT upon binding to amyloid fibrils (Adapted from [103] under
the terms and conditions of the Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/3.0/). (c) Proposed ‘channel’ binding mode
of ThT to amyloid fibrils (Reprinted from Biochimica et Biophysica Acta (BBA) -
Proteins and Proteomics, 1804, M. Biancalanaab, S. Koide, Molecular mechanism of






HEWL (from chicken egg white, protein ≥90%), analytical grade HCl (≥95% purity),
and ThT (≥65% dye content) were purchased from Sigma Aldrich (Dorset, UK) and
used without further purification.
3.1.1 Amyloid Fibril Formation
HEWL fibrils were formed at a concentration of 75 mg ml−1 at pH 2.0 (pH adjusted
with HCl) in Milli-Q water, incubated at 65 ◦C for 72 h.
3.1.2 Thioflavin T Fluorescence Kinetics
ThT was used to monitor the aggregation of HEWL in the presence of preformed HEWL
‘seed’ fibrils. Kinetic measurements were recorded using a CLARIOstar microplate
reader (BMG Labtech, Ortenberg, Germany) in bottom reading mode and half-volume
black 96-well plates (Corning, Kennebunk, USA) sealed using clear polyolefin seal-
ing tape (Thermo Scientific, Rochester, USA). Samples of varying ThT, HEWL, and
HEWL seed fibril concentration were investigated under quiescent conditions at 40 ◦C,
with excitation at 440 nm and emission at 480 nm.
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3.1.3 HEWL Kinetics Under Shear Investigated by Simultaneous Small
Angle X-ray Scattering and Wide Angle X-ray Scattering
3.1.3.1 I22, Diamond
Small-angle X-ray scattering (SAXS) and wide-angle X-ray scattering (WAXS) data
were obtained from the I22 beamline at Diamond Light Source, Oxfordshire, UK. Sam-
ples were loaded into an Anton Paar (Graz, Austria) MCR 501 rheometer with a
SAXS and SANS compatible cup-and-bob sample environment mounted. An 18 keV
(λ = 0.688 A˚) beam was used with a sample-detector distance of 5836 mm. Correc-
tions for the detector flatfield and deadtime were calculated by the Dectris (Baden,
Switzerland) acquisition software with subsequent data processing performed using the
DAWN software package and a set of pipelines developed at Diamond Light Source
[104, 105]. Uncertainty estimates, based on Poisson counting statistics, were calculated
for all measurement data, these were subsequently propagated through the data correc-
tion steps. Each sample measurement was corrected for the following: time, incident
beam flux, transmitted beam flux, solid angle and incident beam polarization. Due
to the complex nature of the rheological setup on the beamline, solvent and cell back-
ground measurements were challenging to accurately and reliably obtain prior to each
measurement. Therefore, the background subtracted from each run is the first frame
of each experiment facilitating the measurement of changes in the scattering pattern
with respect to time.
3.1.3.2 Seeded HEWL Kinetics Under Shear
A solution containing HEWL seeds (3 mg ml−1) and HEWL monomer (60 mg ml−1) at
pH 2.0 (pH adjusted with HCl) in Milli-Q water, was mixed, transferred to the cup-
and-bob sample environment and immediately measured at 65 ◦C under varying shear
rates (25, 50, 100, and 200 s−1).
3.2 NFGAIL
NFGAIL (>95% purity) and NF*G*A*I*L* (* = deuterated amino acids )(>95% pu-
rity, 72% deuteration) were purchased from Peptide Synthetics as their trifluoroacetic
acid (TFA) salts, in a lyophilised powdered form and were used without further purifi-
cation.
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3.2.1 Amyloid Fibril Formation
NFGAIL fibrils were prepared using a modified method that had been previously re-
ported [59]. NFGAIL (12.68 mg, 20 µmol) was dissolved in dimethyl sulfoxide (DMSO)
(40 µL)( ≥99.9% purity, Sigma Aldrich, UK) and sonicated for one minute to ensure
complete dissolution after which sodium phosphate high-performance capillary elec-
trophoresis (HPCE) buffer pH 7.4 (920 µL, 10 mM)(Sigma Aldrich, UK) was added and
mixed. Further sodium phosphate HPCE buffer pH 7.4 (40 µL, 20 mM)(Sigma Aldrich,
UK) was added to this solution to give a solution with a final NFGAIL concentration
of 20 mM. After thorough mixing this solution was incubated at room temperature for
72 hours.
3.2.2 Small Angle Neutron Scattering
3.2.2.1 SANS2D, ISIS
SANS measurements were carried out at ambient temperature on the second-generation
time-of-flight SANS2D instrument at ISIS (Harwell, UK). Sample solutions were mea-
sured in disc-shaped (‘banjo’) quartz cells with a path length of 1 mm (Hellma, Mu¨llheim,
Germany). An incident wavelength range of 2.0-14.0A with a sample-to-detector dis-




. The SANS data collected
was corrected for transmission, background, and pixel sensitivity of the 2-D detector,
and averaged into a 1-D function, I(Q). Data was then scaled to the absolute intensity
for the scattering cross section per unit sample volume (cm−1) using Mantid [106].
Data analysis and modelling was performed in SASView [107].
3.2.2.2 Contrast Match Series
Solutions of hydrogenated NFGAIL seeds in 0, 20, 40, 60, and 80% D2O (Sodium
phosphate HPCE buffer pH 7.4, 10 mM)(Sigma Aldrich, UK) (2.5 mg ml−1) were each
measured in ‘banjo’ cells (250 µL)(Hellma, Mu¨llheim, Germany) at ambient temper-
ature with an acquisition time of 0.5 h. The corresponding buffer solution for each
sample was run under the same conditions.
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3.2.2.3 Small Angle Neutron Scattering Kinetics
A kinetic solution containing hydrogenated NFGAIL seeds (2.5 mg ml−1) and deuter-
ated NFGAIL monomer (13.3 mg ml−1) in 38.5% D2O (Sodium phosphate HPCE buffer
pH 7.4, 10 mM)(Sigma Aldrich, UK) was mixed, transferred to a ‘banjo’ cell (250 µL)
and immediately measured at ambient temperature with an acquisition time of 2 h.
Data was sliced into 10 min time slices using Mantid [106].
3.2.3 Fitting Small Angle Neutron Scattering Data
TEM images were used initially as a guide to particle shape for NFGAIL fibrils. An
elliptical cylinder model with dimensions determined from TEM images was used as
the basis of the model applied to the SANS data. SASView was then used to optimise
the model and improve the ‘goodness of fit’ [107]. The reduced chi-squared values from
SASView were used as a measure of the ‘goodness of fit’, this parameter is related to
the difference between the experimental data and the model. For a good fit to the data,
the value of the reduced chi-squared will tend to 1.
3.3 α-Synuclein
α-synuclein (hydrogenated and perdeuterated, ≥95% purity) was obtained from the
Deuteration Laboratory (D-LAB) (Grenoble, France) as a lyophilised powder and was
used without further purification.
3.3.1 Amyloid Fibril Formation
α-synuclein fibril formation was based on a previously described method [108]. α-
synuclein was dissolved in 20 mM sodium phosphate buffer HPCE pH 7.4 (Sigma
Aldrich, UK) to give 500 µL aliquots at a final concentration of 500 µM. The solu-
tions containing a micro polytetrafluoroethylene magnetic stirrer bar (Fisherbrand,
UK) were incubated for 72 h at 40 ◦C with maximal stirring on a RCT Basic heat plate
(IKA, Staufen, Germany).
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3.3.2 Thioflavin T Fluorescence Kinetics
ThT was used to monitor the aggregation of both hydrogenated and deuterated α-
synuclein in the presence of preformed hydrogenated α-synuclein ‘seed’ fibrils. Kinetic
measurements were recorded using a CLARIOstar microplate reader (BMG Labtech,
Ortenberg, Germany) in bottom reading mode and half-volume black 96-well plates
(Corning, Kennebunk, USA) sealed using sealing tape (Thermo Scientific, Rochester,
USA). Samples of 20 µM ThT, 2 µM hydrogenated α-synuclein seed fibrils, and either
hydrogenated or deuterated α-synuclein (100 µM) were investigated under quiescent
conditions at 37 ◦C, with excitation at 440 nm and emission at 480 nm.
3.3.3 Small Angle Neutron Scattering
3.3.3.1 SANS2D, ISIS
SANS measurements were carried out at ambient temperature on the second-generation
time-of-flight SANS2D instrument at ISIS (Harwell, UK). Sample solutions were mea-
sured in disc-shaped (‘banjo’) quartz cells (Hellma, Mu¨llheim, Germany) with a path
length of 1 mm held in a rotating sample changer. An incident wavelength range of




. The SANS data collected was corrected for transmission, background,
and pixel sensitivity of the 2-D detector, and averaged into a 1-D function, I(Q). Data
was then scaled to the absolute intensity for the scattering cross section per unit sam-
ple volume (cm−1) using Mantid [106]. Data analysis and modelling was performed in
SASView [107].
3.3.3.2 Contrast Match Series
Solutions of hydrogenated α-synuclein seeds in 0, 20, 40, 60, and 80% D2O (Sodium
phosphate HPCE buffer pH 7.4, 10 mM)(Sigma Aldrich, UK)(1.2 mg ml−1) were each
measured in ‘banjo’ cells (250 µL) at ambient temperature with an acquisition time
of 0.5 h. The corresponding buffer solution for each sample was run under the same
conditions.
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3.3.3.3 Small Angle Neutron Scattering Kinetics
A kinetic solution containing hydrogenated α-synuclein seeds (1.2 mg ml−1) and deuter-
ated α-synuclein monomer (2.5 mg ml−1) in 40% D2O (Sodium phosphate HPCE buffer
pH 7.4, 10 mM) was mixed, transferred to a ‘banjo’ cell (250 µL) and immediately mea-
sured at ambient temperature with an acquisition time of 4 h. Data was sliced into
30 min time slices using Mantid [106].
3.3.4 Fitting Small Angle Neutron Scattering Data
TEM images were used initially as a guide to particle shape for α-synuclein fibrils. A
cylinder model with dimensions determined from TEM images was used as the basis of
the model applied to the SANS data. SASView was then used to optimise the model
and improve the ‘goodness of fit’ [107]. The reduced chi-squared values from SASView
were used as a measure of the ‘goodness of fit’, this parameter is related to the difference
between the experimental data and the model. For a good fit to the data, the value of
the reduced chi-squared will tend to 1.
3.4 TTR(105-115) (YTIAALLSPYS)
YTIAALLSPYS (>95% purity), Y*TI*A*A*L*L*SP*YS (Deuterated)(>95% pu-
rity, 72% deuterated), Y*TI*AA*LL*SP*YS (Face-deuterated)(>95% purity, 40%
deuterated) and Y*TI*A*A*L*LSPYS (Side-deuterated)(>95% purity, 37% deuter-
ated) were purchased from Peptide Synthetics as their TFA salts, in a lyophilised pow-
dered form and were used without further purification. Where * denotes the following
deuteration scheme of the amino acid: Y* - Tyrosine ring-D4, I* - Isoleucine D10, L*
- Leucine D10, A* - Alanine (2,3,3,3-D4), P* - Proline D7.
3.4.1 Amyloid Fibril Formation
3.4.1.1 Method 1
YTIAALLSPYS-based peptides were fibrillised based on a previously described method
by Bongiovanni et al. [109]. Each YTIAALLSPYS-based peptide (10 mg) was first fully
dissolved in acetonitrile (100 µL)(≥99.5% purity, Sigma Aldrich, UK), after dissolution
Milli-Q water at pH 2 was added to give a final concentration of 10 mg ml−1. Solutions
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were adjusted to pH 2 with concentrated HCl (≥95% purity, Sigma Aldrich, UK). To
ensure complete mixing, the solutions were vortexed before being sonicated for 5 min.
Once mixed, the solutions were left at room temperature for 72 h to fibrillise.
3.4.1.2 Method 2
YTIAALLSPYS-based peptides were fibrillised based on a previously described method
by Gras et al. [110]. Each YTIAALLSPYS-based peptide (10 mg) was first fully dis-
solved in acetonitrile (100 µL)(≥99.5% purity, Sigma Aldrich, UK), after dissolution
Milli-Q water at pH 2 was added to give a final concentration of 10 mg ml−1 at pH
3. To ensure complete mixing, the solutions were vortexed before being sonicated for
5 min. Once mixed, the solutions were left at room temperature for 72 h to fibrillise.
3.4.2 Neutron Diffraction
3.4.2.1 Sample Preparation
Fibril solutions were freeze-thawed once to increase solution mobility to facilitate pipet-
ting. A droplet of the fibril solution was then deposited on a custom-made, half cylinder,
aluminium sample holder (Figure 3.1)(Aluminium is transparent to neutrons) [111].
Once the solution had evaporated, this deposition process was repeated a further 5
times to generate an amyloid fibril film.
Figure 3.1: Custom-made sample holders for neutron fibre diffraction of dried amy-
loid fibril films.
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3.4.2.2 D19, Institut Laue–Langevin
Neutron fibre diffraction data was recorded using the D19 diffractometer at the Institut
Laue–Langevin (ILL) (Grenoble, France), a monochromatic thermal neutron single
crystal diffractometer, using a wavelength of 2.425A. The samples were mounted at
chi 90°. A 120° × 30° position-sensitive detector was used, where the horizontally
mounted ‘banana’ detector was set symmetrically about the equatorial plane, with the
sample at the centre of horizontal curvature. Data was collected on each sample for at
least 8 hours. The data was background subtracted and divided by the scattering from
vanadium using LAMP [112].
3.4.3 Model Unit Cell and Simulations
Two dummy unit cells representative of a section of the amyloid spine consisting of
two β-strands in each of the two β-sheets were constructed for H/D/D-side and D-face
YTIAALLSPYS fibrils in the program VESTA [113]. Both unit cells had the following
parameters: Space group P1; a = 9.4A; b = 17.6A; c = 36.0A; and, α=β=γ = 90.
Powder neutron diffraction patterns were generated using CrystalDiffract 6.7.3 and a
wavelength of 2.425A [114].
3.5 General Techniques
3.5.1 Amyloid Seed Generation
Amyloid fibril ‘seeds’ were generated using a liquid nitrogen freeze/thaw process re-
peated three times [115]. The freeze/thaw process consisted of Eppendorf tubes con-
taining 500 µL of amyloid fibrils being plunged into liquid nitrogen for 5 min before
being removed and placed into a beaker of water to thaw.
3.5.2 X-ray Fibre Diffraction
Data was collected on a Rigaku Oxford Diffraction Supernova Diffractometer using
CuKα radiation λ = 1.5418A. Measurements were performed at 295 K. Amyloid fibril
seed solution (15 µL) was suspended between two capillaries with wax coated ends.
After being left at room temperature for 5 h, a dried fibril stalk was formed which was
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mounted onto a goniometer for imaging [116]. An acquisition time of 60 s was used to
collect data with a detector distance of 42 mm.
3.5.3 Transmission Electron Microscopy
TEM imaging was carried out using a JEOL JEM-2100 Plus (JEOL, Tokyo, Japan)
operating at 200 kV. Samples were prepared using a previously reported method [96].
Amyloid fibril seed solutions were first diluted to 0.01-0.5 mg ml−1 in Milli-Q water,
before a small aliquot (5 µL) was pipetted onto a 300-mesh carbon-coated copper grid
that had been glow discharged. The solution was left to adsorb for 30 s before a wedge
of filter paper was used to wick the solution off the copper grid. The grid was then
rinsed with distilled H2O after which an aliquot of 2% (w/v) uranyl acetate was applied
and left to stain for 30 s. The stain was then wicked away using filter paper and the




and a Label-Free Assay
This chapter consists of two sections. The first section of this chapter focuses on in-
vestigating HEWL aggregation kinetics at high concentrations using ThT fluorescence
kinetics. The second section of this chapter focuses on a Diamond Light Source ex-
periment where lysozyme aggregation was investigated under shear, using SAXS as a
label-free assay to follow aggregation.
4.1 Introduction
4.1.1 Lysozyme Elongation Kinetics
HEWL aggregation has been extensively studied since Pepys et al. reported that muta-
tions in human lysozyme was linked with hereditary systemic amyloidosis [117]. HEWL
is highly homologous to human lysozyme and investigating lysozyme aggregation may
have therapeutic benefits for treating amyloidosis [50].
HEWL is often used as a model protein for investigating amyloid aggregation due
to the wealth of information available regarding its structure and folding properties
[51]. HEWL has been aggregated under a multitude of conditions leading to different
aggregation pathways [52–58]. Investigations using HEWL as a model protein may
allow determination of structural and mechanistic principles that could be applied in
general to amyloid fibrils.
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Once initial aggregates of amyloid have formed it can be hard to prevent further ag-
gregation or reverse the formation of the aggregates [108]. It is therefore a necessity to
understand the mechanism of aggregation in the presence of ‘seeds’ (preformed aggre-
gates).
The presence of seeds can greatly increase the rate of aggregation and simplify the
analysis of aggregation kinetics [118]. Seeds bypass the slow primary nucleation step
that forms initial aggregates and allows for faster, templated elongation in which pre-
formed fibril seed ends grow. The main kinetic steps present in seeded experiments are
elongation and secondary nucleation. In secondary nucleation, the fibril seed surface is
used as a catalyst to form an amyloid nucleus which can then elongate; leading to the
possibility of autocatalytic amplification [119].
Seeded aggregation kinetics where primary and secondary nucleation is minimal is pre-
dicted to be exponential due to the constant number of fibril seed ends and successively
decreasing monomer concentration [108]. The rate of fibril elongation is expected to be
proportional to monomer concentration at low concentrations, but begins to saturate
at higher concentrations. At low concentrations diffusion of monomers to fibril seed
ends is the rate-limiting step [120]. However, at higher concentrations the rate-limiting
step becomes reorganisation of the monomer once it has attached to a fibril seed end
[121]. The concentration-dependence of the elongation rate can be compared to that
of Michaelis–Menten kinetics [122].
Here, HEWL was used as a model protein to investigate elongation rate concentration
dependence at high monomer concentration using ThT fluorescence kinetics.
4.1.2 Label-Free Assay for Amyloid Aggregation
As there have been many links between amyloid fibril aggregation and disease, there
has been a huge interest in finding molecules that could slow down or prevent the
aggregation of amyloidogenic proteins [123–129].
The fluorescent dye ThT is one of the most widely used molecules to identify amyloid
fibrils, both ex vivo and in vitro. It is considered a ‘gold standard’ for the qualitative
and quantitative detection of amyloid fibrils and many studies use ThT to determine
the effect a chosen inhibitor may have on aggregation kinetics [130–132].
Although ThT is widely used to follow amyloid kinetics it also has many drawbacks.
The interactions between fibrils and ThT, as well as the intensity of the ThT fluores-
cence are affected by pH and buffer viscosity [133]. Both acidic and basic pH have been
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shown to significantly affect the intensity of ThT fluorescence. Hackl et al. state that
care should be taken when performing ThT assays at low or high pH as the effect pH
has on ThT could be responsible for false positives or negative results [134]. Viscous
environments have been shown to vastly increase the fluorescence intensity of ThT
[135].
In addition to detecting amyloid fibrils, ThT can also fluoresce in the presence of DNA,
cyclodextrin, and SDS micelles [133]. This could cause problems when trying to follow
amyloid kinetics in a mixed system modelled after physiological conditions.
Small molecules used to inhibit amyloid aggregation can also affect ThT fluorescence
due to competitive inhibition with ThT and spectral overlap [136, 137]. Rifampicin
has been used as a molecular inhibitor for a range of polypeptides however there were
contrary reports on the effectiveness of Rifampicin to inhibit aggregation of islet amy-
loid polypeptide (IAPP), which is linked to type 2 diabetes [138, 139]. Meng et al.
reported that Rifampicin did not inhibit aggregation of IAPP or cause IAPP fibrils
to disaggregate. Rifampicin was shown to have no significant effect on the kinetics
of IAPP aggregation but was shown to interfere with the ThT assay and give a false
positive [140].
Oligomers that are formed during amyloid aggregation have been reported to be the
main toxic species associated with amyloids [141]. Being able to monitor the presence
of oligomers allows insight into their toxicity and allows testing of inhibitors that could
prevent oligomer formation. However, ThT does not report on amyloid oligomers or
early aggregates; it only reports on mature amyloid fibrils. ThT fluorescence experi-
ments also do not directly report on the presence or growth of amyloid polymorphs.
However, circular dichroism of ThT can report on the presence of polymorphs but
necessitates further experiments in addition to fluorescence spectroscopy [142].
It has been highlighted that the use of an extrinsic label could affect aggregation kinetics
and introduces a component that would not be present under physiological conditions
[137]. There have also been studies that have suggested that ThT can inhibit or pro-
mote amyloid aggregation. Fodera` et al. and Manno et al. have both suggested that
ThT affects the aggregation of insulin [143, 144]. Fodera` et al. suggests there is a con-
centration dependent inhibition of the aggregation by ThT and Manno et al. suggests
that the presence of ThT can delay the onset of aggregation, whereas, D’Amico et al.
suggests, that the aggregation rate of the peptide Aβ40 is enhanced by the presence of
ThT [145].
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4.1.3 Amyloid Polymorphism and Breakage
Understanding amyloid polymorphism is of great interest due to fibril morphology being
directly linked to cell toxicity [146].
Tanaka et al. investigated yeast prion strains and were surprised to find that the
strain with the fastest elongation rate was not the strain that dominated [147]. In fact,
they discovered that the strain with the slowest elongation rate dominated; there were
additional factors that affected strain dominance. Although the dominant strain had
a slow elongation rate, it had an increased propensity to fragment due to increased
brittleness. The greater number of growing ends overcame the slow elongation rate.
They suggested that aggregate fragility is strongly linked to physiological impact.
Agitated conditions such as stirring or shaking have been shown to induce formation
of polymorphs compared to fibrils formed under quiescent conditions [17].
Kurouski et al. reported that small differences in the pH of the aggregation solution for
lysozyme fibrils caused a marked difference in the morphology of the fibrils [146]. They
reported that lysozyme fibrils formed at pH 1.0-1.5 had a flat tape-like morphology
whilst lysozyme fibrils formed at pH 2.7 had a twisted morphology. Using vibrational
circular dichroism they were able to determine that lysozyme fibrils formed at pH 2.3
were an almost equal mixture of the fibrils formed at pH 1.0-1.5 and pH 2.7.
Here we aim to investigate lysozyme aggregation kinetics and polymorphic behaviour
as a function of shear rate by using an in-situ rheometer and a combined SAXS/WAXS
technique. Applying a shear force during seeded lysozyme fibrillisation may lead to the
emergence of a dominant polymorph which has a faster elongation rate or a greater
propensity to fragment.
The development of a label-free assay for amyloid aggregation that is not hindered
by solution conditions would be an extremely useful tool for investigating amyloid
species and their aggregation. A combined SAXS/WAXS technique should allow not
only monitoring of amyloid aggregation but also real time structural and morphological
data from hydrated samples over a range of length scales.
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4.2 Results and Discussion
4.2.1 Characterisation of Lysozyme Fibrils
The morphology of HEWL fibrils was characterised using X-ray fibre diffraction and
TEM.
4.2.1.1 X-ray Fibre Diffraction
X-ray fibre diffraction of a dried stalk of HEWL fibrils prepared at pH 2 gave character-
istic rings at 4.7A and 9.6A, representative of the cross-β structure present in amyloid
fibrils [148]. These characteristic rings confirmed the formation of amyloid fibrils from
the protein (Figure 4.1). The reflections are in agreement with those previously re-
ported [52].
Figure 4.1: X-ray fibre diffraction (2D) image of lysozyme fibrils. Lysozyme fibrils
were formed at a concentration of 75 mg ml−1 at pH 2.0 in Milli-Q water, incubated at
65 ◦C for 72 h. Lysozyme fibrils were freeze-thawed once and an aliquot of the solution
(15 µL) was suspended between two wax ends at room temperature for 5 h, to form a
dried fibril stalk.
4.2.1.2 Transmission Electron Microscopy
TEM of HEWL fibrils (Figure 4.2) prepared at pH 2 indicated a flexible cylindrical
morphology with diameter of 7.9± 1.3 nm (Average of 20 measurements), in agreement
with that previously reported for HEWL fibrils formed under these conditions [52].
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Figure 4.2: TEM of lysozyme fibrils. Lysozyme fibrils were formed at a concentration
of 75 mg ml−1 at pH 2.0 in Milli-Q water, incubated at 65 ◦C for 72 h. Lysozyme fibrils
were freeze-thawed three times and diluted to 0.01 mg ml−1 in Milli-Q water, an aliquot
of the solution (5µL) was then deposited on a copper grid for imaging.
4.2.2 Thioflavin T Fluorescence Kinetics
Previously, ThT intensity has been reported to have a linear relationship with amyloid
fibril concentration. However, this relationship was determined at lower fibril con-
centrations [149]. Due to these experiments using higher fibril concentrations than
previously reported, the relationship between ThT intensity and fibril concentration
was investigated over a higher concentration range (Figure 4.3). A variety of ThT
concentrations were investigated to determine the optimal concentration for reporting
on amyloid fibril aggregation under these conditions.
From Figure 4.3, it is apparent that over the higher fibril concentration range stud-
ied there is a non-linear relationship for all concentrations of ThT. At higher fibril
concentrations the ThT fluorescence intensity began to plateau.
However, if only the fibril seed concentration range up to 8 mg ml−1 is investigated,
a linear relationship is reported (Figure 4.4). A HEWL fibril concentration of up
to 2.5 mg ml−1 was studied by Ow and Dunstan, and showed a linear relationship
between ThT and fibril concentration [150]. It is a possibility that ThT has a non-linear
dependence on fibril concentration but experiments thus far have investigated amyloid
concentrations which fall within a linear region. Therefore in the following experiments
an approximately linear relationship can be applied for fibrils concentrations up to
8 mg ml−1.
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Figure 4.3: HEWL seed concentration against fluorescence intensity over a range of
ThT concentrations.
Figure 4.4: HEWL seed concentration (Up to 8 mg ml−1) against fluorescence inten-
sity over a range of ThT concentrations.
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A ThT concentration of 20 µM was found to give maximum sensitivity in response to
amyloid fibrils and for this reason was chosen as the working ThT concentration for
further experiments. A further reason was that at this concentration, ThT should not
interfere with aggregation kinetics [149]. This concentration of ThT was within the
range commonly used and recommended by previous studies [149, 151, 152].
To determine that only elongation was being measured and there was no significant
primary nucleation occurring over the timescale of the experiment, monomer in the
presence and absence of seeds was investigated (Figure 4.5). The unseeded experiment
showed no increase in ThT intensity over the time course of the experiment (17 h).
This result indicated that primary nucleation did not significantly contribute to the
aggregation kinetics over the course of the experiment. However, in the presence of
seeds there was significant aggregation over this time frame. The kinetic trace was not
sigmoidal suggesting minimal contributions from secondary processes; with elongation
being the major aggregation pathway. The initial decline in ThT fluorescence intensity
was attributed to the previously reported phenomenon of samples warming to the
experimental temperature within the plate reader [153].
























Figure 4.5: HEWL monomer (80 mg ml−1) was aggregated in the absence and pres-
ence of fibrils seed (2 mg ml−1) at 40 ◦C under quiescent conditions and was monitored
over 17 h by ThT fluorescence. The shaded region depicts the standard deviation of
the kinetic trace from three repeats.
The change in fluorescence intensity of seed solutions (in the absence of monomer) over
time (Figure 4.6) was then investigated to determine stability of the seeds over the
experimental timeframe. It was apparent from Figure 4.6 that there was not signifi-
cant degradation of the fibril seeds under these conditions over the chosen timeframe.
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However, for the higher seed concentrations there was a significant increase in ThT
intensity over time. HEWL seeds were not purified after incubation so the increase in
intensity could have been due to elongation of the seeds by unfibrillised HEWL that
was still present after incubation.




























Figure 4.6: HEWL fibril seeds incubated at varying concentrations under quiescent
conditions at 40 ◦C.
As there was no significant formation of fibrils by primary nucleation and the aggre-
gation occurred in the presence of fibril seeds, the mass concentration of fibrils, M(t),
during the initial aggregation kinetics can be described using [121, 154],
M (t) = m (0)C+e
κt −m (0)C−e−κt, (4.1)
t→0





where m(t) is the concentration of free monomer in solution, P(t) is the number con-
centration of fibrils and O is derived by Lorenzen et al. [121]. The constants in







κ ± M(0)2m(0) ,
(4.3)
where k˜+ is the elongation rate constant from each end of a fibril seed, k2 is the sec-
ondary pathway rate constant and n2 is a variable that describes whether the secondary
pathway is monomer dependent or independent [155, 156].
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From Equation 4.1 it is apparent that during initial aggregation in the presence of
seeds, the depletion of monomer m(t) is mainly governed by elongation of fibril seed
ends.






= 2k˜+m (0)P (0) , (4.4)
where P(0) is the initial seed number concentration and M(0) is the initial seed mass
concentration.
Firstly, the effect of seed concentration on the elongation kinetics of HEWL was inves-
tigated and is presented in Figure 4.7. For the concentration of seeds that was used in
these experiments, the change in the fluorescence of the seeds over time (Figure 4.6) is
within the error for the seeded kinetics and was determined to be negligible (Figure 4.8).



























Figure 4.7: HEWL monomer (40 mg ml−1) was aggregated in the presence of varying
concentrations of fibril seeds at 40 ◦C under quiescent conditions and was monitored
over 17 h by ThT fluorescence.
The kinetic experiments with varying seed concentrations and fixed initial monomer
concentration (Figure 4.7) showed an initial ThT intensity proportional to seed mass
concentration and an initial aggregation rate proportional to the initial seed number-
concentration (Figure 4.8), as would be expected by Equation 4.4. For each of the
experiments a known mass concentration of fibril seeds M(0) was used and seeds gen-
erated from a single aliquot was used to seed each experiment. Seeds taken from the
same aliquot were expected to have the same average length <L(0)>. The number
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concentration of seeds P(0) is equal to M(0)/<L(0)>. Consequently, both the initial
ThT intensity and initial aggregation rate are predicted to be linearly dependent on
fibril seed mass concentration. This linear dependence is verified in Figure 4.9 and
4.10.























Figure 4.8: HEWL monomer (40 mg ml−1) aggregated in the presence of fibril seeds
(8 mg ml−1) (Solid line) and HEWL fibril seeds (8 mg ml−1) (Dotted line) incubated
at 40 ◦C under quiescent conditions monitored by ThT fluorescence.




















Figure 4.9: Initial elongation rates show a linear dependence with seed concentra-
tion.
Secondly, the effect of monomer concentration on the elongation kinetics of HEWL
was investigated and is presented in Figure 4.11. Previous studies have reported that
the monomer concentration dependence of the elongation rate for seeded aggregation
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Figure 4.10: A plot of log[Fibril] versus log(Rate), giving a rate order of 1.
can be compared to that of Michaelis–Menten kinetics [122]. At low concentrations
diffusion of monomers to fibril seed ends is the rate-limiting step [120]. However, at
higher concentrations the rate-limiting step becomes reorganisation of the monomer
once it has attached to a fibril seed end [121]. The elongation rate dependence on
monomer concentration for seeded aggregation is therefore given as,
r0 = 2k˜+m (0)P (0) =
2k+m (0)
1 +K−1m m (0)
P (0) , (4.5)
where k+ is a true elongation rate constant that does not depend on monomer con-
centration and Km is the crossover concentration which is the concentration at which
aggregation is no longer diffusion limited and instead becomes rearrangement limited.
Equation 4.5 shows that at low monomer concentrations (K−1m m (0)  1) elongation
rate increases linearly with monomer concentration, and at high monomer concentra-
tion (K−1m m (0)  1) the elongation rate saturates and is no longer dependent on the
monomer concentration.
However, these experiments (Figure 4.11) did not follow the theory and maintained
concentration dependence at very high monomer concentrations. Not only were the
experiments monomer concentration dependent at high concentrations, there was not
a linear relationship across the monomer concentration range. The rate order can be
treated as,
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Figure 4.11: HEWL monomer of varying concentration was aggregated in the pres-
ence of fibril seeds (2 mg ml−1) at 40 ◦C under quiescent conditions and was monitored
over 17 h by ThT fluorescence.
initial rate ∝M(0)n, (4.6)
where n is the rate order. By taking the log of each side:
log initial rate ∝ n logM(0). (4.7)
A plot of log(initial rate) against logM(0) should give a straight line. The slope of the
reaction should be equal to the rate order. A log-log graph was plotted to determine
the rate order with respect to monomer concentration (Figure 4.12).
Figure 4.12: A plot of log[monomer] against log(initial rate) for seeded HEWL
aggregation (The data has been plotted as two distinct regions).
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As can be seen from Figure 4.12, the log-log graph could not be fitted by a single
straight line. There appears to be two distinct regions of monomer concentration
dependence; a region at low monomer concentration and another region at higher
monomer concentration. The rate order for each region is shown in Table 4.1. At
low concentration the concentration dependence was determined to be linear (first
order) and at the higher concentration the rate order was concluded to be fourth order
with respect to initial monomer concentration. The experiments were repeated and
the phenomenon at high concentration was reproduced (Figure 4.13). The gradient for
each region and experiment is compared in Table 4.1.
Figure 4.13: Plots of log[monomer] against log(initial rate) for repeated seeded
HEWL aggregation experiments: (a) Repeat 1 and (b) Repeat 2. Shaded areas show
the distinct regions.
Table 4.1: Gradients for lower and higher concentration regions of log[monomer]
versus log(initial rate) plots of HEWL seeded amyloid kinetics.
Experiment Region 1 Gradient Region 1 Error Region 2 Gradient Region 2 Error
1 0.95 ±0.23 4.26 ±0.09
2 0.44 ±0.03 3.86 ±0.24
3 0.44 ±0.04 3.12 ±0.17
Average 0.61 ±0.17 3.75 ±0.33
Although Experiment 1 displayed a linear relationship at low monomer concentration
(rate order 0.95 ± 0.23) and approximately fourth order at higher monomer concen-
tration (rate order 4.26 ± 0.09), Experiment 2 and 3 showed a lower monomer concen-
tration rate order giving an average of 0.61 ± 0.17.
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Surprisingly, the three experiments give an average rate order of 3.75 ± 0.33 for the high
concentration region suggesting the possibility that there is a change in kinetic pathway
at high concentration. The increased conversion of free monomer to fibrillar mass could
be explained by a switch from a monomer addition pathway at low concentration to an
oligomer addition pathway at high concentration. Hill et al. reported that lysozyme
fibrils transitioned from monomeric to oligomeric fibril assembly as the result of salt-
mediated charge screening [157]. Furthermore, the high concentration of HEWL may
have caused molecular crowding in the solution [158]. In this crowded environment,
higher order assembly would be favoured due to the reduction in excluded volume
compared to that of the free monomer [159]. This could drive oligomer formation of
HEWL which would reduce the excluded volume, addition of oligomers to the fibril
seeds would then further reduce the excluded volume.
4.2.2.1 Combined Small Angle X-ray Scattering/Wide Angle X-ray Scat-
tering Assay to Follow Lysozyme Aggregation
The following section discusses a Diamond Light Source experiment where seeded
lysozyme aggregation kinetics was investigated under controlled shear (Rheometer),
using SAXS and WAXS simultaneously.
The viscosity of the fibril solutions throughout the kinetic experiments were recorded by
the rheometer. From Figure 4.14 it is visible that the rheology data shows a sigmoidal
profile, which is common for amyloid aggregation. It is also apparent that as the shear
rate increases, the time taken to reach a plateau decreases. This suggests that higher
shear rates cause an increase in the rate of fibril breakage [160]. An increased number
of fibril seeds leads to an accelerated rate of monomer consumption. Also, the decrease
in final viscosity is consistent with shorter fibrils.
For a rod-like particle, which has a length much larger than its other dimensions, the
scattering curve can be split into two factors, one that is related to the length of the
rod and one that arises from the cross-sectional factor [161]. It has been hypothesised
that the forward scattering intensity at zero angle of the cross-sectional factor, Ic(0),
could be used as a measure of fibrillar content.
By applying a modified Guinier plot to the SAXS pattern arising from each timepoint
and plotting the resulting Ic(0) values against time, a kinetic trace can be determined
(Figure 4.14). Both the rheology data and the Ic(0) show a sigmoidal profile rep-
resentative of amyloid aggregation. By overlaying the rheology data and Ic(0) data
(Figure 4.14), comparisons between the two datasets can be made. There is a strong
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correlation between each set of Ic(0) data and the corresponding rheology data. In
addition to matching the sigmoidal profile of the rheology data, the Ic(0) traces have
an exponential growth phase which occurs at the same time as the rheology data.
















































































Figure 4.14: Combined plots of viscosity and I0 versus time for seeded HEWL ag-
gregation experiments at various shear rates. HEWL seeds (3 mg ml−1) and HEWL
monomer (60 mg ml−1) at pH 2.0 (pH adjusted with HCl) in Milli-Q water were mea-
sured at 65 ◦C under varying shear rates (25, 50, 100, and 200 s−1).
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The simultaneous use of SAXS and WAXS was utilised to give the potential of two
methods to follow structural and kinetic changes throughout the experiment. It was
expected that the intensity of the 4.7A peak, associated with the cross-β structure
present in amyloid fibrils, could be used as a measure of fibrillar content, whilst the ap-
pearance or disappearance of peaks within the WAXS region would provide information
on fibrillar structural changes.
The complex nature of the rheological setup on the beamline caused several problems
and hindered analysis of the WAXS data. Problems such as bubbles in solution and
a large sample cell to detector gap made accurate WAXS measurements difficult. Due
to these problems the intensity of the 4.7A peak over time could not be compared
alongside the Ic(0) data. The 2D WAXS patterns for the endpoint of seeded HEWL
aggregation under various shear rates are shown in Figure 4.15 and the 1D patterns
are shown in Figure 4.16.
The most prominent signals in the 2D WAXS data were two arcs at 4.1A (1.31 Q,
Outer arc) and 4.8A (1.52 Q, Inner arc). The presence of arcs rather than rings shows
that the fibrils have been partially aligned by the shear flow. The arc at 4.8A can
be attributed to the inter-strand spacing of the cross-β structure which is typically
given as 4.7A. The inter-sheet spacing ( 8-10A) associated with the cross-β structure
appears to be absent but this may be due to the signal being of low intensity as a result
of the problems encountered. With the current data it is difficult to determine where
the 4.1A spacing arises from. However, it is interesting that the 4.1A arc is in the same
alignment as the inter-strand spacing of the fibrils. The problems encountered during
the experiment made drawing meaningful conclusions from the WAXS data extremely
difficult.
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(a) (b)
(c) (d)
Figure 4.15: 2D WAXS patterns for the endpoint of seeded HEWL aggregation
under various shear rates: (a) 25 s−1; (b) 50 s−1; (c) 100 s−1, (d) 200 s−1.


















Figure 4.16: 1D WAXS patterns for the endpoint of seeded HEWL aggregation
under various shear rates.
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4.3 Conclusions
4.3.1 Lysozyme Elongation Kinetics
In conclusion, seeded HEWL aggregation at very high concentrations, using ThT fluo-
rescence kinetics, does not follow the predicted dependence of initial elongation rate on
monomer concentration. Current research suggests that at low monomer concentration
the elongation rate should increase linearly with monomer concentration, and at high
concentration the elongation rate should saturate and no longer be dependent on the
monomer concentration [121]. This relationship has been reported for other proteins,
such as α-synuclein, insulin, Sup35 yeast prion and S6 [108, 120–122]. Instead, the
results in this thesis show the elongation rate increasing linearly with low monomer
concentration as predicted, but at very high monomer concentration it shows the elon-
gation rate is strongly dependent on the monomer concentration. This is an important
result as the change in concentration dependence at high concentration could suggest
a change in elongation pathway. Further experiments are required to understand the
seeded kinetics at very high concentrations. Previously, HEWL aggregation has been
shown to change from a monomeric assembly pathway to an oligomeric pathway as a
result of salt concentration [157]. The proposed model suggested salt-mediated charge
screening at high salt concentrations made the formation of compact oligomers more
favourable, both energetically and entropically, leading to an increased concentration of
oligomers which could aggregate to form fibrils through oligomer addition. We hypoth-
esise that in this thesis, molecular crowding caused by high HEWL concentration drives
oligomer formation and switches the elongation pathway from monomeric to oligomeric
addition at high HEWL concentration. As oligomeric species have been reported to be
the most toxic amyloid species, this research further reiterates the necessity to prevent
high concentrations of amyloid proteins within the body, caused by amplified expression
and reduced clearance of proteins [66, 141].
4.3.2 Label-Free Assay for Amyloid Aggregation
These results have shown that SAXS can successfully be employed as a label-free tech-
nique to follow amyloid kinetics. This is important as it will allow measurement of
amyloid aggregation without the use of an extrinsic label which could alter the mor-
phology of the fibrils formed or affect the aggregation rate [134, 143–145]. With the
absence of an extrinsic label this technique would allow better mimicking of physi-
ological conditions in comparison to ThT fluorescence kinetics, which is the current
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standard [102, 137]. Additionally, this technique could be used in the investigation of
small molecules which inhibit fibrillation. ThT fluorescence kinetics may incorrectly
report on fibril concentration when small molecule inhibitors are present [140]. This is
due to ThT often having a similar structure to small molecule inhibitors which can lead
to competitive inhibition of ThT binding to fibrils or spectral overlap which quenches
the ThT signal [151]. As the developed technique does not require a label molecule it
would not encounter these problems. Future work would benefit from testing a wide
range of fibrillisation conditions such as temperature, shear rates, pH, seed concen-
tration and monomer concentration. Refining the current procedure used to analyse
the data would allow greater accuracy in reporting fibril concentration. Unfortunately,
the combined use of a rheometer and a SAXS/WAXS technique proved difficult and
hindered the analysis of the WAXS data. Therefore, the WAXS data could not be
used as an additional method to follow amyloid aggregation. If this experiment was
repeated, the combined SAXS/WAXS technique would benefit from an improved rheo-
logical setup on the beamline. However, this technique should be viable under quiescent
conditions for other experiments. In the future, with further development of this tech-
nique and increased access to laboratory-based SAXS machines, this protocol could






Currently, the most commonly used experimental techniques to probe the kinetics of
amyloid fibril growth are limited and can usually only probe the overall percentage of
protein in the fibrillised form versus the unfibrillised form, and the rate of change of
these percentages. Techniques such as light scattering [162], fluorescence spectroscopy
[163], and turbidity have been used to probe the kinetics [164]. This is limiting due to
the rate of change being dependent on two different variables, the average rate of growth
for a single amyloid fibril, and the number (and length distribution) of the amyloid
fibrils. The techniques utilised cannot differentiate between the two variables, which
means that direct comparison between seeded amyloid fibril growth experiments for
different proteins or peptides is not viable. We currently cannot successfully determine
in the comparison of two different protein amyloid fibril growth experiments, whether
the kinetics for one experiment is faster than the other because the elongation of the
fibrils is faster, or because instead there were a greater number of shorter fibrils present
in the fibril seed stock solution.
To determine the length of fibrils in the seed stock solution, techniques such as TEM
and atomic force microscopy (AFM) could be used to measure a length distribution,
although these often tend to be quite subjective measurements due to the selection of
interpretable images for quantification [165, 166]. If the value of the length distribution
was used in conjunction with a technique such as fluorescence spectroscopy to measure
the overall percentage of fibrillised protein, then it could allow for the measurement
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of an elongation rate. However, this value would depend on the reliability of the
measured length distribution. Techniques such as TEM and AFM require the removal
of an aliquot of sample and extensive sample preparation. Both techniques require a
sample to be deposited onto a surface, washing of the surface and then leaving the
sample to dry. If the measured length distribution is not representative of the bulk,
then the results will be skewed; this can occur when some fibril lengths or polymorphs
have a greater affinity to the surface than others [167]. Also, the drying process can
affect the morphology of the fibrils [168]. The drying process could disrupt fibrils into
smaller fragments, not giving an accurate representation of the fibril lengths in the bulk
solution [169].
Recent studies have been aimed at the development of techniques that can overcome
these problems by directly measuring the growth of individual amyloid fibrils. These
studies have used techniques such as quartz crystal microbalance sensors [170], atomic
force microscopy [171], and total internal reflection fluorescence microscopy [169].
Single molecule techniques such as AFM began to emerge as methods to directly observe
the growth of amyloid fibrils and determine their elongation rates in-situ. Single amylin
fibril growth on a mica surface was observed over time by Goldsbury and colleagues
[172]. However, these techniques also had their own limitations which became apparent
once two parallel experiments were carried out. In the first experiment, the amylin
fibrils were left to grow in a test tube, and in the second experiment, a droplet of the
amylin solution was placed on a piece of mica to grow fibrils. A significant discrepancy
in the morphologies of the fibrils formed arose from the two different conditions. The
dominant fibril size formed on the mica had a height 2.4 nm, whereas this height of
fibril was very rare in the test tube sample. Instead, fibrils formed in the test tube
sample showed a height of 6.8 nm, comparable with TEM. This discrepancy between
fibrils formed on the mica surface and fibrils formed in solution suggests that the
elongation rate of the amyloid fibrils on the mica surface would not be representative
of the fibrils that form and grow in solution. It is suggested that there are possibly
constraints present for the fibrils that grow on surfaces due to immobilisation. In this
experiment, the surface effects of the mica constrained the growth of the fibrils to that
of protofibrils. In contrast, fibrils formed in test tubes are able to move in solution
and interact without constraint to form thicker fibrils via coiling of the protofibrils.
Properties of the mica surface, such as hydrophobicity, hydrophilicity and charge are
highly influential on the growth rate and morphology of the fibrils, as shown by other
researchers [173–175]. Also, the data can be hard to analyse if the scan rate of the AFM
experiment is close to or slower than the fibril growth rate and there are concerns that
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the AFM measurement may also influence the kinetics through interactions with the
probe tip. [176].
A novel approach to the direct observation of amyloid fibril growth kinetics has recently
been published which uses super-resolution microscopy [177]. The technique utilises
two-colour direct stochastic optical reconstruction microscopy (dSTORM) to monitor
the growth of individual fibrils at various stages of growth by using differently labelled
fibril seeds and monomers. The protein investigated was α-synuclein which is associated
with Parkinson’s disease. To visualise the difference between α-synuclein monomer and
fibrils using dSTORM, two different batches of modified α-synuclein monomer were
produced. One batch had covalently labelled cysteine variants (N122C) of the protein
with the dye Alexa Fluor 647 (red), whilst the other used the dye Alexa Fluor 568
(green). Fibril seeds were formed using the Alexa Fluor 568 labelled batch and the
monomeric Alexa Fluor 647 batch was added to perform a seeded fibrillation assay to
visualise fibril elongation. Throughout the reaction, aliquots of the solution were taken
and deposited onto a glass coverslip for the dSTORM imaging. The formed fibrils
would then consist of the initial seed which would be labelled with the green dye, and
the extended region which had formed from addition of the monomeric protein labelled
with the red dye. In addition to directly observing distinct individual fibrils throughout
the aggregation process, they were also able to explicitly confirm that both ends of the
fibril seeds grew during fibril aggregation, giving rise to evidence for the bidirectional
growth of fibrils, which has been a highly contested concept in amyloid fibril research
[178, 179].
However, as the protein monomers have been modified through labelling with fluo-
rescent molecules it can be suggested that these labels could have an effect on the
structural morphology of the amyloid fibrils formed and also lead to a change in the
kinetics of growth [180, 181].
In this work, we aim to develop a new method exploiting SANS to investigate linear
extension rates of amyloid fibril elongation in solution, whilst also determining the
number (and average length) of the fibril seeds. This information will be vital in
improving the understanding of amyloid and prion diseases, whilst also furthering the
foundation of the theoretical understanding of peptide fibrillation kinetics based on
molecular models.
Linear extension rates of amyloid fibril growth and concentration of fibril ends will
be independently measured using a deuterated labelling method. A length distribution
from the initial fibril seeds can be determined as the concentration of the rods is a mea-
sure of the concentration of fibril ends. The lengths of the rods can then be measured
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over time and the increased length of the rods can be used to calculate a linear growth
rate for an individual fibril. As previously mentioned, selective deuteration of a com-
ponent within a multi-component system can be used along with solvent “matching”
of components to allow investigation into specific parts of a system.
t = 0 t = End
Figure 5.1: A simple schematic diagram showing the elongation of hydrogenated
“seeds” (red rods) by deuterated monomeric protein (blue rods).
Here we used hydrogenated NFGAIL amyloid fibril seeds and deuterated NFGAIL
peptide to allow for contrast variation experiments to determine linear extension rates
of NFGAIL amyloid fibril growth by measuring the increase of fibril lengths over a range
of time points. Hydrogenated amyloid fibril seeds in H2O/D2O solvent were mixed
with deuterated NFGAIL peptide. The growth of the fibrils will then occur from the
deuterated NFGAIL peptide growing on the end of the hydrogenated NFGAIL seeds
(Figure 5.1). After a range of suitable time periods of growth, the deuterium labelled
ends can be investigated by SANS and modelled as a fixed number concentration of
rods, each growing in length. If the scattering length density (SLD) of the H2O/D2O
solvent is “matched” to the SLD of the hydrogenated fibril seeds, then we will only see
contribution to the scattering from the deuterium labelled ends. The increase in length
of these deuterated fibril ends over time can then be used as a direct measurement of
linear extension rates.
5.2 Results and Discussion
5.2.1 Characterisation of NFGAIL Fibrils
Before linear extension rates and fibril end concentrations could be determined, the
NFGAIL fibrils had to first be characterised. Once characterised, a suitable model
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could be determined for the growing deuterium labelled ends which could then be
applied to the contrast matched SANS experiment.
5.2.1.1 X-ray Fibre Diffraction
X-ray fibre diffraction of a dried stalk of NFGAIL fibrils gave characteristic rings at
4.7A and 8-10A, representative of the cross-β structure present in amyloid fibrils.
These characteristic rings confirm the formation of amyloid fibrils from the peptide
precursor. As the 2D image (Figure 5.2) shows rings rather than arcs, it can be deduced
that there is no preferential alignment of fibrils in the stalk sample.
Figure 5.2: X-ray fibre diffraction (2D) image of NFGAIL fibril stalk. NFGAIL
fibrils were formed at a concentration of 12.68 mg ml−1 at pH 7.4 in sodium phosphate
buffer (10 mM), incubated at room temperature for 72 h. NFGAIL fibrils were freeze-
thawed once and an aliquot of the solution (15µL) was suspended between two wax
ends at room temperature for 5 h, to form a dried fibril stalk.


















Figure 5.3: X-ray fibre diffraction (1D) image of NFGAIL fibril stalk (Same condi-
tions as above).
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5.2.1.2 Transmission Electron Microscopy
TEM of NFGAIL fibrils (Figure 5.4) indicates a twisted ‘ribbon-like’ morphology with a
minor dimension of ≈ 15 nm and major dimension of ≈ 26 nm, as well as an axial helical
periodicity of ≈ 200 nm (Average of 20 measurements). These values are in agreement
with those previously reported for NFGAIL fibrils. Tenidis and colleagues reported
branching and coiling features of the NFGAIL fibrils, from which they suggested the
mature fibrils consisted of an assembly of at least two filaments [59]. The current
resolution is not sufficient to allow an accurate determination of whether or not the
fibrils consist of multiple filaments.
Figure 5.4: TEM image of NFGAIL fibrils. NFGAIL fibrils were formed at a con-
centration of 12.68 mg ml−1 at pH 7.4 in sodium phosphate buffer, incubated at room
temperature for 72 h. NFGAIL fibrils were freeze-thawed three times and diluted to
0.1 mg ml−1 in Milli-Q water, an aliquot of the solution (5 µL) was then deposited on
a copper grid for imaging.
5.2.1.3 SANS
An elliptical cylinder model was used to fit the scattering curve arising from the hydro-
genated NFGAIL fibrils seeds (2.5 mg ml−1) in 80% D2O (Figure 5.5) [182]. The model
corresponds to an elliptical cylinder with minor radius = 7.4± 0.1 nm, major radius =
14.6± 0.2 nm and a length = 70.3± 3.3 nm. The agreement between the experimental
data and the fit is reasonable. However, there appears to be a discrepancy between
the modelled lengths from SANS and the measured lengths from TEM. The error in
the model from SANS appears to underestimate the variation in lengths present in the
TEM. At low Q there is a divergence of the experimental data from the model, which
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could be attributed to higher order aggregation such as fibril-fibril association [83]. A






















Figure 5.6: Schematic diagram of (H)NFGAIL fibrils (Determined from an elliptical
fit to the measured SANS data for hydrogenated NFGAIL seeds in 80% D2O).
5.2.1.4 Mass per Unit Length
The mass per unit length (MPUL) can be calculated by first determining the y-intercept
(Ic(0)) of a modified Guinier plot, arising from hydrogenated NFGAIL fibril seed scat-
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Figure 5.7: Modified Guinier plot of (H)NFGAIL SANS profile.
Where, M is the mass-per-unit-length of the fibril, d is the mean density of a protein
(1.35 g ml−1), NA is Avogadro’s number (6.022× 1023 mol−1), C is the concentration
of peptide in the fibril seeds (1.27 mg ml−1), ρp is the scattering length density of the
fibril seeds (2.41× 1010 cm−2) and ρs is the scattering length density of the solvent
(4.99× 1010 cm−2). Using these values the mass-per-unit-length of the NFGAIL fibrils
was determined to be 19 220 ± 320 Da/A. The MPUL can be roughly estimated using
the dimensions of the fibrils determined from TEM/SANS and the mean density of a




Where V is the volume of a fibril with a cross-sectional area determined from TEM/SANS
and in this case a length of 1A (33 942A
3
), d is the mean density of a protein
(1.35 g ml−1) and NA is Avogadro’s number (6.022× 1023 mol−1). Using this equa-
tion gave a rough MPUL estimate of 27 600 Da/A. Based on the estimated value, the
experimental value determined from a modified Guinier plot of NFGAIL fibril seed
scattering is a sensible value.
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5.2.2 NFGAIL Elongation Kinetics
5.2.2.1 Contrast Match Series
To monitor only the growing deuterated ends of the fibrils, the scattering contribution
from the hydrogenated seeds must be removed. When the SLD of the solvent is matched
to that of hydrogenated seeds, the contrast between the solvent and the seeds is zero.
At this contrast match point the measured intensity from the seeds is zero. A contrast
match series where the component to be matched is prepared at the same concentration
in different mixtures of H2O/D2O solvent can be used to determine the contrast match
point.
The resultant scattering curves from hydrogenated NFGAIL seeds in 0, 20, 40, 60, and
80% D2O (2.5 mg ml
−1) are shown in Figure 5.8. Common practise in determining the
contrast match point from a contrast match series is to plot the square root of the
intensity at low Q versus the volume fraction of D2O. Values obtained at negative
contrast, where the SLD of the H2O/D2O solvent is lower than SLD of the NFGAIL
seeds are treated as negative. Applying a linear regression to the resultant data gives
rise to the volume fraction of D2O with minimal contrast (Figure 5.9). The contrast
match point for hydrogenated NFGAIL seeds is XD2O = 0.385. This value is in good





















Figure 5.8: Contrast match series of hydrogenated NFGAIL fibrils (2.5 mg ml−1) in
varying H2O/D2O solvents.
73
NFGAIL Linear Elongation SANS 5.2. Results and Discussion













Figure 5.9: Square root of the intensity at low Q versus the volume fraction of D2O
for hydrogenated NFGAIL fibrils. Values treated as negative (negative contrast) are
shown in grey.
5.2.2.2 Elongation
Using the contrast match point XD2O = 0.385, a kinetic experiment was carried out
where deuterated NFGAIL (13.3 mg ml−1) was grown on hydrogenated NFGAIL seeds


















Figure 5.10: SANS scattering of (D)NFGAIL with elliptical cylinder fit.
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An infinitely long elliptical cylinder model was used to fit the scattering curve arising
from the deuterated NFGAIL fibril ends in 38.5% D2O. The model corresponds to an
elliptical cylinder with minor radius = 3.0± 0.1 nm, major radius = 9.0± 0.3 nm and a
length too long to accurately measure. The agreement between the experimental data
and the fit is reasonable. The apparent dimensions of the deuterated NFGAIL fibrils
ends are shown in Figure 5.11. The cross-section determined from the deuterated fibril
ends is different to that from the hydrogenated fibril seeds. This was surprising, as it
was expected that the hydrogenated seeds would template the growth of the deuterated





Figure 5.11: Schematic diagram of (D)NFGAIL fibrils.
The dimensions of the cross-section for the deuterated model were applied to the scat-
tering curves arising from the kinetic experiment at increasing time points to deter-
mine length values (Figure 5.12). The fits to the data were better at later timepoints
due to an increased signal-to-noise ratio compared to the earlier timepoints. At later
timepoints the growing deuterated ends were long and scattered strongly, whereas at
earlier timepoints the growing deuterated ends were short and scattered weakly. It
was assumed that there weren’t correlations between ends of the same fibril due to the
semi-flexible nature of the fibrils.
Plotting the length values obtained from the deuterated NFGAIL ends at subsequent
time points as a function of time gives a graph of length versus time (Figure 5.13), a
linear elongation rate can be extracted from the slope of a linear fit applied to the plot.
The linear extension rate for NFGAIL fibrils was found to be 1.9± 0.1 nm min−1.
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Figure 5.12: Kinetic SANS of hydrogenated NFGAIL fibrils with growing deuterated
ends at subsequent time points.














Figure 5.13: A plot of length versus time for NFGAIL fibril seed elongation.
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This result appears reasonable compared to other reported elongation rates of amyloid
fibrils. Goldsbury and colleagues reported an elongation rate of 1.1 nm min−1 for the
assembly of an amylin protofibril on mica measured with AFM [172], whilst Wo¨rdehoff
and colleagues reported an elongation rate of 8.5± 3.7 nm min−1 for α-synuclein fibrils
measured using total internal reflection fluorescence microscopy [184].
5.2.3 Number of Ends/Seed Length
In addition to the linear extension rate, further information such as fibril seed sizes can
be extracted and validated using the kinetic SANS of NFGAIL fibrils.
5.2.3.1 Validating the Elongation Rate and Monitoring Secondary Kinetic
Processes
The SANS coherent macroscopic scattering cross section for monodisperse particles in












Where (N/V ) is the number density of particles, Vp is the volume of the particle, ∆ρ
2
is the contrast factor, P (Q) is the form factor and S(Q) is the structure factor.
For the case where Q = 0 and the solution is dilute, P (Q) = 1 and S(Q) = 1. The








Where I(0) is the scattering intensity at the zero angle.
As I(0) ∝ Vp2, if the length of the seeds increases linearly with time then I(0) will have
a squared relationship with time (Figure 5.14). The values of I(0) for each time point
in the SANS kinetic experiment can be determined from a Guinier plot. Furthermore,
a plot of Length2 versus I(0) will give a linear relationship (Figure 5.15).





or ∆ρ2. As there is
not significant deviation from the expected relationships, it can be inferred that there





over the time course of the experiment. A constant value
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would argue against any significant breakage or secondary nucleation during
the experiment. The system can then be treated as a fixed number of growing ends.












Figure 5.14: A plot of I(0) versus time for NFGAIL fibril seed elongation.

















Figure 5.15: A plot of Length2 versus I(0) for NFGAIL fibril seed elongation.
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5.2.3.2 Estimating Fibril Seed Lengths
The fibril seed lengths can be estimated from the kinetic SANS and the hydrogenated
NFGAIL fibril seed scattering, using the fibril seed concentration, the MPUL of the seed
fibrils and the number density of seeds. The fibril seed concentration is already known
from the experimental preparation and the MPUL of the seed fibrils was calculated

















If the growth of the fibril ends is assumed to bidirectional, then there will be two



















Using the number density of the seeds, the known concentration of seeds and the MPUL




SL is the fibril seed length (nm), C is the concentration of fibril seeds (mg ml
−1), M
is the mass-per-unit-length of the hydrogenated fibrils (gA
−1
), and Ns is the number
density of seeds.
The fibril seed lengths were estimated to be 91± 20 nm (Figure 5.16). This value is
within an order of magnitude of the fibril seed lengths given by TEM. In addition, the
fibril seed length estimate is in good agreement with the seed length determined by
SANS (Figure 5.6).
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Figure 5.16: Fibril seed lengths determined from the SANS kinetics.
5.3 Conclusion
In this chapter, a contrast matching SANS technique was developed which demon-
strated the ability to measure amyloid fibril elongation rates in bulk solution. Although
NFGAIL was chosen as the peptide system to be investigated, this technique could be
applied to other peptide systems which aggregate to form amyloid fibrils. We believe
that the elongation rate reported for NFGAIL fibrils in this thesis (1.9± 0.1 nm min−1)
is the first reported elongation rate for NFGAIL fibrils.
In addition to measuring the elongation rate of the fibrils, this technique was able
to simultaneously determine the mass-per-unit-length of the fibrils, the number con-
centration of fibrils, estimate the average seed length used in the kinetic experiment
and determine if there was any significant breakage or secondary nucleation during the
aggregation kinetics. We believe that the mass-per-unit-length reported for NFGAIL
fibrils in this thesis (19 220 ± 320 Da/A) is the first reported mass-per-unit-length for
NFGAIL fibrils. It is important that this technique can simultaneously measure all
these parameters as the most commonly used experimental techniques to probe the
kinetics of amyloid fibril growth are limited to measuring the overall concentration of
protein in the fibrillised form compared to the unfibrillised form [26]. This conversion
is dependent on the average growth rate of fibrils and the number of seed fibrils present
in solution. Current techniques cannot differentiate between these two variables, and
are therefore unable to viably compare between seeded amyloid fibril growth experi-
ments for different proteins and peptides. As the contrast matching SANS technique
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developed in this chapter can measure both the average growth rate of fibrils and the
number of seed fibrils present in solution, it allows viable comparison of amyloid fibril
growth experiments between different proteins and peptides.
However, this technique is currently limited due to it not being able to accurately
measure elongation rates for amyloid fibril systems with fast elongation rates. If the
amyloid fibril elongation rate is too fast, then the growing ends become too long to
accurately measure with current detectors before we are able to acquire images with
suitable signal-to-noise ratios. In the future, as SANS equipment improves, beamlines
which can measure longer particles accurately over shorter timeframes would allow






Often, a model system is investigated before applying the results to a more complex
system. For amyloid systems, short peptide models have been used to investigate and
understand the mechanisms behind amyloid fibril kinetics and formation.
After applying the SANS contrast matching technique to a short peptide (NFGAIL)
with promising results, a more complex protein system was investigated (α-Synuclein).
6.1 Results and Discussion
6.1.1 Characterisation of α-Synuclein Fibrils
Before linear extension rates and fibril end concentrations could be determined, the
α-synuclein fibrils had to first be characterised. Once characterised, a suitable model
could be determined for the growing deuterium labelled ends which could then be
applied to the contrast matched SANS experiment.
6.1.1.1 X-ray Fibre Diffraction
X-ray fibre diffraction of a dried stalk of α-synuclein fibrils gave characteristic signals at
4.7A, 6.9A and 8.9A, representative of the cross-β structure present in amyloid fibrils.
These characteristic arcs confirm the formation of amyloid fibrils from the protein
precursor. As the 2D images (Figure 6.1 and 6.2) show arcs rather than rings, it can be
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determined that there is partial alignment of the fibrils in the stalk samples. Serpell et
al. investigated the diffraction pattern of synthetic filaments formed from full-length
wild-type human α-synuclein using X-ray fibre diffraction. They reported a strong ring
at a spacing of 4.7A and a more diffuse, weaker reflection at 10-11A [185]. Nielsen et
al. also investigated wild-type α-synuclein fibrils, collecting X-ray fibre diffraction at
MAX-lab beamline 911-2 (Lund, Sweden). They also reported reflections at 4.7A and
11A. However, in addition to these reflections, they reported two reflections at 8.3A
and 9.7A appearing as two concentric rings, and a weaker reflection at 6.5A. The
reflections at 4.7A, 6.5A and 8.3A recorded by Nielsen et al. roughly agree with those
reported in this thesis (4.7A, 6.9A and 8.9A).
Figure 6.1: X-ray fibre diffraction image of hydrogenated α-Synuclein fibrils. α-
Synuclein fibrils were formed at a concentration of (500 uM) at pH 7.4 in sodium
phosphate buffer (20 mM), incubated at 40 ◦C for 72 h with maximal stirring. α-
synuclein fibrils were freeze-thawed once and an aliquot of the solution (15µL) was
suspended between two wax ends at room temperature for 5 h, to form a dried fibril
stalk.
Figure 6.2: X-ray fibre diffraction image of deuterated α-Synuclein fibrils. Deuter-
ated α-Synuclein fibrils were formed at a concentration of (500 uM) at pH 7.4 in
sodium phosphate buffer (20 mM), incubated at 40 ◦C for 72 h with maximal stirring.
α-synuclein fibrils were freeze-thawed once and an aliquot of the solution (15 µL) was
suspended between two wax ends at room temperature for 5 h, to form a dried fibril
stalk.
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6.1.1.2 Transmission Electron Microscopy
TEM of α-synuclein fibrils (Figure 6.3, 6.4, 6.5, and 6.6) shows a cylindrical morphology
with a radius ≈ 6 nm (Average of 20 measurements). These values are in agreement
with those previously reported for α-synuclein fibrils [186].
Figure 6.3: TEM image of hydrogenated α-Synuclein fibrils. α-Synuclein fibrils
were formed at a concentration of (500 uM) at pH 7.4 in sodium phosphate buffer
(20 mM), incubated at 40 ◦C for 72 h with maximal stirring. α-Synuclein fibrils were
freeze-thawed three times and diluted to 0.1 mg ml−1 in Milli-Q water, an aliquot of
the solution (5µL) was then deposited on a copper grid for imaging.
Figure 6.4: TEM image of hydrogenated α-Synuclein fibrils (Higher Magnification).
α-Synuclein fibrils were formed at a concentration of (500 uM) at pH 7.4 in sodium
phosphate buffer (20 mM), incubated at 40 ◦C for 72 h with maximal stirring. α-
Synuclein fibrils were freeze-thawed three times and diluted to 0.1 mg ml−1 in Milli-Q
water, an aliquot of the solution (5 µL) was then deposited on a copper grid for imaging.
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Figure 6.5: TEM image of deuterated α-Synuclein fibrils. Deuterated α-Synuclein
fibrils were formed at a concentration of (500 uM) at pH 7.4 in sodium phosphate buffer
(20 mM), incubated at 40 ◦C for 72 h with maximal stirring. Deuterated α-Synuclein
fibrils were freeze-thawed three times and diluted to 0.1 mg ml−1 in Milli-Q water, an
aliquot of the solution (5 µL) was then deposited on a copper grid for imaging.
Figure 6.6: TEM image of deuterated α-Synuclein fibrils (Higher Magnification).
Deuterated α-Synuclein fibrils were formed at a concentration of (500 uM) at pH
7.4 in sodium phosphate buffer (20 mM), incubated at 40 ◦C for 72 h with maximal
stirring. Deuterated α-Synuclein fibrils were freeze-thawed three times and diluted to
0.1 mg ml−1 in Milli-Q water, an aliquot of the solution (5 µL) was then deposited on
a copper grid for imaging.
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6.1.1.3 Thioflavin T Fluorescence Kinetics
It is generally accepted that deuterium labelling does not affect the kinetics or struc-
ture of the samples being studied. However, recently it was shown that aggregation of
perdeuterated transthyretin (TTR) occurred at a different rate to hydrogenated TTR
[71]. The X-ray structures of the perdeuterated and hydrogenated TTR were essentially
identical but the kinetic rates of amyloid aggregation were different. Fluorescence ki-
netics of hydrogenated α-synuclein seeds with hydrogenated α-synuclein monomer and
hydrogenated seeds with deuterated monomer was performed (Figure 6.7). Results from
one set of experiments appeared to show that hydrogenated seed with hydrogenated
monomer aggregated faster than hydrogenated seeds with deuterated monomer, shown
by the steeper initial slope and faster time to plateau. Due to the limited amount of
deuterated α-synuclein that was available, further experiments could not be performed.

























Figure 6.7: Kinetics of α-Synuclein amyloid formation followed by ThT fluores-
cence. Samples of 20 µM ThT, 2µM hydrogenated α-synuclein seed fibrils, and either
hydrogenated or deuterated α-synuclein (100µM) were investigated under quiescent
conditions at 37 ◦C, with excitation at 440 nm and emission at 480 nm.
6.1.1.4 SANS
A cylinder model was used to fit the scattering curve arising from the hydrogenated
α-synuclein fibril seeds (1.2 mg ml−1) in 80% D2O (Figure 6.8) [182]. The model cor-
responds to a cylinder with radius = 6 nm (based on TEM measurements), and an
infinitely long length. The agreement between the experimental data and the fit is
reasonable. At low Q there is a divergence of the experimental data from the model,
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which could be attributed to higher order aggregation such as fibril-fibril association





















Figure 6.9: Schematic diagram of (H) α-Synuclein fibrils (Determined from a cylin-
drical fit to the measured SANS data for hydrogenated α-Synuclein seeds in 80%
D2O).
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6.1.1.5 Mass per Unit Length
The MPUL can be calculated by first determining the y-intercept (Ic(0)) of a modified
Guinier plot, arising from hydrogenated α-synuclein fibril seed scattering (9.00× 10−3
± 5.00× 10−4 cm−1A−1)(Figure 6.10), and applying it to the following equation [83]:

























Where, M is the mass-per-unit-length of the fibril, d is the mean density of a protein
(1.35 g ml−1), NA is Avogadro’s number (6.022× 1023 mol−1), C is the concentration
of protein in the fibril seeds (1.2 mg ml−1), ρp is the scattering length density of the
fibril seeds (2.77× 1010 cm−2) and ρs is the scattering length density of the solvent
(4.99× 1010 cm−2). Using these values the mass-per-unit-length of the α-synuclein
fibrils was determined to be 4830 ± 280 Da/A. Dearborn et al. used scanning trans-
mission electron microscopy (STEM) to investigate α-synuclein fibrils reporting a mean
mass-per-unit-length of 5910 Da/A [187]. There is reasonable agreement between the
mass-per-unit-length determined by STEM and SANS.
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6.1.2 α-Synuclein Elongation Kinetics
6.1.2.1 Contrast Match Series
To monitor only the growing deuterated ends of the fibrils, the scattering contribu-
tion from the hydrogenated seeds must be removed and so the same contrast variation
methods were employed as in Chapter 5. A contrast match series was used to deter-
mine the match point for hydrogenated seeds. The resultant scattering curves from
hydrogenated α-synuclein seeds in 0, 20, 40, 60, and 80% D2O (1.2 mg ml
−1) are shown
in Figure 6.11. The contrast match series was evaluated in the same method as the pre-
vious chapter. The contrast match point for hydrogenated α-synuclein seeds is XD2O
= 0.4 (Figure 6.12). This value is in good agreement with the expected contrast match




















Figure 6.11: Contrast match series of hydrogenatedα-Synuclein fibrils (1.2 mg ml−1)
in varying H2O/D2O solvents.
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Figure 6.12: Square root of the intensity at low Q versus the volume fraction of D2O
for hydrogenated α-Synuclein fibrils. Values treated as negative (negative contrast)
are shown in grey.
6.1.2.2 Elongation
Using the contrast match point XD2O = 0.4, a kinetic experiment was performed
whereby deuterated α-synuclein monomer (2.5 mg ml−1) was grown on hydrogenated
α-synuclein seeds (1.2 mg ml−1). The resultant scattering curve from the endpoint of


















Figure 6.13: SANS scattering of (D) α-Synuclein seeds with cylinder fit (radius =
6 nm and length = infinite).
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An infinitely long cylinder model was used to fit the scattering curve arising from the
deuterated α-synuclein fibrils ends in 40% D2O. The model corresponds to a cylinder
with radius = 6 nm and a length too long to accurately measure, matching the model
determined from the hydrogenated seeds. Due to the large error in the data points at
high Q , data in the range of up to 0.07A
−1
was used for the model. The large error in
the data at high Q was believed to be the result of oversubtraction. This suggested that
the composition of the model buffer solution was different to that of the seed solution
background. This may have been due to salts or compounds from the protein being
released during aggregation. The agreement between the experimental data and the fit
is reasonable.
The cross-section dimensions of this model was applied to the scattering curves aris-
ing from the kinetic experiment at increasing time points to determine length values
(Figure 6.14(a)). To determine the repeatability of these experiments a second kinetic
experiment was performed under the same conditions (Figure 6.14(b)). For these ex-
periments there was also a large error in the data points at high Q. Therefore, data
in the range of up to 0.07A
−1
was used for the model. The large error in the data
at high Q was believed to be the result of oversubtraction. This suggested that the
composition of the model buffer solution was different to that of the reaction solution
background. This may have been due to salts or compounds from the protein being
released during aggregation.
Plotting the length values obtained from the deuterated α-synuclein ends at subsequent
time points as a function of time gives a graph of length versus time (Figure 6.15), a
linear elongation rate can be extracted from the slope of a linear fit applied to the plots.
The linear extension rate for α-synuclein fibrils was found to be 0.73± 0.13 nm min−1
in the first experiment and 0.59± 0.11 nm min−1 in the second experiment, giving an
average of 0.66± 0.09 nm min−1. This result appears reasonable compared to other
reported elongation rates of amyloid fibrils, discussed in the previous chapter. Buell
and colleagues reported an average elongation rate of ∼1 nm min−1 for α-synuclein fib-
rils in phosphate-buffered saline measured with fluorescence kinetics, whilst Wo¨rdehoff
and colleagues reported an elongation rate of 8.5± 3.7 nm min−1 for α-synuclein fib-
rils measured using total internal reflection fluorescence microscopy [108, 184]. Our
results are in close agreement with those of Buell and colleagues but do not agree with
Wo¨rdehoff and colleagues results. Surface effects present in the total internal reflection
fluorescence microscopy technique which could accelerate elongation rates may explain
the disparity between Wo¨rdehoff’s results and the results presented here. The good
agreement between elongation values from both of the kinetic experiments suggests the
data from the SANS contrast matching technique is reproducible.
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Figure 6.15: A plot of length versus time for α-Synuclein fibril seed elongation.
6.1.3 Number of Ends/Seed Length
In addition to the linear extension rate, further information such as fibril seed sizes can
be extracted and validated using the kinetic SANS of α-synuclein fibrils.
6.1.3.1 Validating the Elongation Rate and Monitoring Secondary Kinetic
Processes
The SANS coherent macroscopic scattering cross section for monodisperse particles in
a solvent is described in the previous chapter.
As discussed in the previous chapter, as I(0) ∝ Vp2, if the lengths of the seeds increase
linearly with time then I(0) should have a squared relationship with time (Figure 6.16).
The values of I(0) for each time point in the SANS kinetic experiment can be deter-
mined from a Guinier plot. Furthermore, a plot of Length2 versus I(0) should give a
linear fit (Figure 6.17).





or ∆ρ2. As there is
no significant deviation from the expected relationships, it can be suggested that there











would argue against any significant breakage or secondary nucleation during
the experiment. The system can then be treated as a fixed number of growing ends.
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Figure 6.16: A plot of I(0) versus Time for α-Synuclein fibril seed elongation.
















Figure 6.17: A plot of Length2 versus I(0) for α-Synuclein fibril seed elongation.
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6.1.3.2 Estimating Fibril Seed Lengths
The fibril seed lengths can be estimated from the kinetic SANS and the hydrogenated
α-synuclein fibril seed scattering, using the fibril seed concentration, the mass-per-
unit-length (MPUL) of the seed fibrils and the number density of seeds. The fibril seed
concentration is already known from the experimental preparation and the MPUL of
the seed fibrils was calculated previously using the hydrogenated α-synuclein fibril seed
scattering. The growth of α-synuclein fibrils was assumed to be bidirectional and the
equations from the previous chapter were used to estimate the fibril seed lengths [177].
The fibril seed lengths were estimated to be 2100± 900 nm (Figure 6.18(a)) from the
first kinetic run and 1600± 700 nm (Figure 6.18(b)) from the second kinetic run, giving
an average of 1900± 600 nm. This value is within an order of magnitude of the fibril
seed lengths given by TEM.
At later timepoints where the fibril ends are approaching a q range where the length
appears ‘infinite’, the error in determining the length of the growing ends, and I(0)
increases causing a large error in the estimation of the fibril seed lengths.
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Figure 6.18: The initial α-Synuclein fibril seed lengths present in the SANS kinetics
was determined from the scattering at each timepoint over the course of the elongation
kinetics and averaged to give an estimate: (a) (Top) Kinetic Run 1; (b) (Bottom)
Kinetic Run 2.
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6.2 Conclusion
In this chapter, a contrast matching SANS technique, which was developed in the
previous chapter to measure amyloid fibril elongation rates in bulk solution, was applied
to a protein system. As this technique had been proven to be successful in measuring
amyloid fibril elongation rates for a short model peptide, it was tested on a more
complex protein system. The amyloid fibril system investigated was that of the protein
α-synuclein. The technique was successful in measuring the elongation rate of the α-
synuclein fibrils, suggesting that the technique that had been developed could be used
to measure a wide range of amyloid fibrils formed from both peptides and proteins.
The technique shows good repeatability, giving a low variance between two separate
kinetic runs. The benefits and drawbacks of this technique outlined in the previous
chapter are also applicable to measuring protein systems.
This technique provided a new way of measuring amyloid fibril elongation rates. The av-
erage elongation rate of α-synuclein fibrils was determined to be 0.66± 0.09 nm min−1.
The values reported by this procedure corresponded to results from previous research
measured using fluorescence kinetics, where measurements were performed in solu-
tion (∼1 nm min−1) [108]. However when measurements were carried out on surfaces
using total internal reflection fluorescence microscopy, elongation rates were faster
(8.5± 3.7 nm min−1) [184]. As the developed technique utilises solution scattering it
does not require an extrinsic label nor for the sample to be immobilised on a sur-
face; these conditions are required for fluorescence kinetics and total internal reflection
fluorescence microscopy and may influence the elongation rate [108, 145, 173, 184].
Additionally, the technique provides a bulk solution method to measure the mass-per-
unit-length of amyloid fibrils, which gave a mass-per-unit-length for α-synuclein fibrils
of 4830 ± 280 Da/A. This value was similar to that measured by the commonly used
single molecule STEM technique (5910 Da/A) but did not require extensive sample
preparation or analysis [187].
As we have developed a technique that allows the measurement of protein fibril elon-
gation rates, it would be beneficial to test small molecules or species that may block,
inhibit or accelerate fibril elongation and quantify their effect. Several small polyphe-
nols have been shown to be effective in inhibiting amyloid formation and this technique
could be used to investigate other polyphenolic compounds which could potentially in-
hibit or block elongation [7]. Glycosaminoglycans are associated with amyloid deposits
in vivo and have been reported to accelerate amyloid aggregation, quantifying the effect
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of different glycosaminoglycans on the elongation rate using our technique would be of
great interest [44].
Further work would be required to investigate if there truly are any kinetic differences
caused through the use of deuterium labelling [71]. If the deuterated peptides/proteins
affect the kinetics of aggregation, it would also be useful to investigate the effect of




TTR1 Neutron Fibre Diffraction
7.1 Introduction
Several models have been proposed to represent the structure of amyloid fibrils [188].
Jahn et al. concluded that amyloid fibrils can be best described by the cross-β structural
model [189]. This model consists of what is described as an ‘amyloid spine’ [190]. A
pair of β-sheets that are parallel to the fibril and run the length of the fibril is the basis
of the spine [12]. The β-strands within the β-sheets are orientated perpendicular to
the fibril axis, and compact interdigitation of the β-strand side chains binds the two
β-sheets. The interface between the two β-sheets is completely dry and this geometry
is termed a ‘steric zipper’ [191].
Several steric zipper symmetries have been reported. Stroud derived all possible steric
zipper interactions, depicted in Figure 7.2 [192].
Investigating the ‘packing’ of the amyloid spine has been hindered by the nature of
amyloid fibrils [193]. Amyloid fibrils are long, polydisperse fibres that are insoluble,
preventing effective use of techniques such as solution-phase NMR and X-ray crystal-
lography which have been successful in determining high resolution protein structure
[87]. However, progress in techniques such as scanning proline mutagenesis [194], solid-
state NMR [76], electron paramagnetic resonance [195], cryo-electron microscopy and
X-ray fibre diffraction has allowed investigation into these details [14, 196].
Several short peptides that form amyloid-like microcrystals have been investigated using
diffraction techniques, from which a crystal structure was determined [15, 197]. It is
unclear whether the packing in the crystals is truly representative of packing in a fibril
[12].
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We aim to develop a new technique utilising neutron fibre diffraction and deuterium
labelling of amyloidogenic peptides to deduce the packing system formed by the peptide
in the fibril [198, 199].
The only previous neutron diffraction studies of amyloid systems were presented by
Tiggelaar et al., who demonstrated the feasibility of the technique [89]. Tiggelaar et al.
did not employ labelling schemes or extract packing information in their study. The
focus of their study was H2O/D2O substitution by humidification to investigate the
role of water in amyloid fibrils.
Here we chose to investigate the peptide YTIAALLSPYS (TTR(105–115)), an 11-
residue peptide from transthyretin, henceforth referred to as TTR1 [110]. TTR1 was
chosen as it is one of the most studied model peptides that forms amyloid fibrils;
it is well characterised and the atomic-resolution structure of TTR1 fibrils has been
reported [11, 77, 200–202]. Fitzpatrick et al. used a combination of STEM, AFM, cryo-
EM, magic angle spinning NMR and X-ray fibre diffraction to determine the atomic-
resolution structure of TTR1 amyloid fibrils. The fibrils were shown to have a twisted
morphology with a diameter of 100-200A and a typical length of 1-3 µm. The packing
system determined by Fitzpatrick et al. for TTR1 fibrils is shown in Figure 7.1.
Figure 7.1: Atomic-resolution structure of the TTR1 protofilament determined by
magic angle spinning NMR. β-strands are depicted as blue ribbons, and odd- and even-
numbered side chains are depicted as orange and pink sticks, respectively. Hydrogen-
bonding is depicted as dashed yellow lines. (A) The β-sheet viewed perpendicularly
to the fibril axis illustrating the parallel in-register β-strands and the hydrogen bonds.
(B) Cross-sectional view of the two-sheet protofilament along the peptide chain direc-
tion (Reprinted from reference [11]).
The atomic-resolution structure of the TTR1 fibrils consisted of parallel, in-register
β-sheets with an interbackbone hydrogen-bonding network. The peptide chain length
was reported as 38A, the distance between β-strands was reported as 4.67A and the
distance between β-sheets was reported as 8.86A. The atomic-resolution structure of
the TTR1 fibrils shows the packing within the fibrils to be of steric zipper group 4.
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To differentiate between the steric zipper groups a deuterium labelling scheme was de-
vised, shown in Figure 7.3. By selectively deuterating the ‘side’ or the ‘face’ of the
peptide, the packing environment in the amyloid fibril can be elucidated using neu-
tron fibre diffraction. The simplified steric zipper models arising from the deuterated
‘face’ TTR1 ((D-face) TTR1)Y*TI*AA*LL*SP*YS and deuterated ‘side’ ((D-side)
TTR1)Y*TI*A*A*L*LSPYS are shown in Figure 7.4 and 7.5, respectively. Each of
the (D-face) and (D-side) models corresponds to several of the steric zipper groups
shown in Figure 7.3, but by cross-checking the (D-face) and (D-side) models that
represent the experimentally determined fibre diffraction, a single steric zipper group
describing the structure in TTR1 fibrils can be derived.
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Figure 7.2: The 15 steric zipper groups. A section of the amyloid spine con-
sisting of two β-strands in each of the two β-sheets is depicted. Each cuboid
represents a β-strand, and each coloured face denotes orientation of the β-strand.
One of the β-sheets is bounded by a dashed rectangle; the β-sheets run par-
allel to the fibril axis illustrated by a red arrow. (Adapted from [192] under
the terms and conditions of the Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/)).
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Figure 7.3: The four deuterium labelling schemes of TTR1 (YTIAALLSPYS (Hy-
drogenated), Y*TI*A*A*L*L*SP*YS (Deuterated), Y*TI*AA*LL*SP*YS
(Face-deuterated) and Y*TI*A*A*L*LSPYS (Side-deuterated)) shown as a simpli-
fied model (a, c, e, and g) and as a peptide model (b, d, f, h), respectively (Deuterium
labelled amino acids are shown in purple).
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(a) (b)
(c) (d)
Figure 7.4: The four steric zipper models arising from (D-face) TTR1: (a) Parallel,




Figure 7.5: The four steric zipper arising from (D-side) TTR1: (a) Parallel, mir-
rored; (b) Parallel, unmirrored; (c) Anti-parallel, mirrored; and, (d) Anti-parallel,
unmirrored.
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7.2 Results and Discussion
7.2.1 Characterisation of TTR1 Fibrils
7.2.1.1 X-ray Fibre Diffraction
To determine if deuterium labelling affected the structure of the amyloid fibrils formed
from TTR1, the fibrils were characterised using X-ray fibre diffraction. Although neu-
tron diffraction can easily distinguish between hydrogen and deuterium, X-ray diffrac-
tion cannot and therefore if the structures of the differently labelled TTR1 fibrils are
the same, the resulting X-ray diffraction patterns should also be the same.
Initially, fibril formation of the variously labelled TTR1 peptides was based on a previ-
ously reported method where the resuspended peptides were incubated at pH 2 [203].
Figure 7.6 shows the 2D XRD images of the TTR1 fibrils prepared at pH 2 and Figure
7.7 shows the 1D patterns. The presence of amyloid fibrils was confirmed by the char-
acteristic rings at 4.7A and ∼ 8-10A corresponding to the distance between β-strands
and β-sheets, respectively [148]. Whilst (H) and (D) TTR1 fibrils contained reflections
at 4.7A and 8.8A agreeing with previously reported literature for TTR1 fibrils, (D-
side) and (D-face) TTR1 fibrils had an equatorial reflection at 9.6A corresponding to
the distance between β-sheets in the amyloid spine [203, 204]. The difference in the
β-sheet spacing between (H)/(D) and (D-side)/(D-face) TTR1 fibrils verified that two
distinct polymorphs had been formed.
Fibril formation was then repeated using a second previously reported method where
the resuspended peptides were not pH adjusted before incubation (pH 3) [110]. Figure
7.11 shows the 2D X-ray fibre diffraction images of the TTR1 fibrils (pH 3). The dried
stalks of the variously labelled TTR1 fibrils gave characteristic signals at 4.7A and
8.8A, representative of the cross-β structure present in amyloid fibrils [205]. These
peaks correspond with those previously reported for TTR1 fibrils and with those de-
termined for (H) and (D) TTR1 fibrils formed at pH 2 [206]. These characteristic arcs
confirm the formation of amyloid fibrils from the peptide precursor. As the 2D images
(Figure 7.11) showed arcs rather than rings, it can be determined that there was par-
tial alignment of the fibrils in the stalk samples. No discernible difference is apparent
between the 2D patterns. Comparison of the 1D patterns (Figure 7.9) also showed no
discernible difference between the peak positions for each sample.
TTR1 fibrils formed without pH adjustment (pH 3) were selected to be investigated by
neutron fibre diffraction due to the polymorph formed being well characterised [76].
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(a) (b)
(c) (d)
Figure 7.6: X-ray fibre diffraction images of the four labelled TTR1 fibrils prepared
at pH 2: (a) (H) TTR1; (b) (D) TTR1; (c) (D-side) TTR1, (d) (D-face) TTR1.
TTR1 fibrils were formed at a concentration of 10 mg ml−1 at pH 2.0 in Milli-Q water,
incubated at room temperature for 72 h. TTR1 fibrils were freeze-thawed once and
an aliquot of the solution (15 µL) was suspended between two wax ends at room
temperature for 5 h, to form a dried fibril stalk.




















Figure 7.7: X-ray fibre diffraction 1D image of TTR1 fibrils (pH 2).
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(a) (b)
(c) (d)
Figure 7.8: X-ray fibre diffraction images of the four labelled TTR1 fibrils prepared
at pH 3: (a) (H) TTR1; (b) (D) TTR1; (c) (D-side) TTR1, (d) (D-face) TTR1.
TTR1 fibrils were formed at a concentration of 10 mg ml−1 at pH 3.0 in Milli-Q water,
incubated at room temperature for 72 h. TTR1 fibrils were freeze-thawed once and
an aliquot of the solution (15 µL) was suspended between two wax ends at room
temperature for 5 h, to form a dried fibril stalk.


















Figure 7.9: X-ray fibre diffraction 1D image of TTR1 fibrils (pH 3).
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7.2.1.2 Transmission Electron Microscopy
Further investigation into the (D-side)/(D-face) TTR1 fibril polymorph formed by in-
cubation at pH 2 was carried out using TEM. Figure 7.10(a), 7.10(b), 7.10(c) and
7.10(d) show images of (H), (D), (D-side) and (D-face) TTR1 fibrils formed at pH 2,
respectively. Whilst (H) and (D) TTR1 fibrils exhibited a twisted morphology com-
monly reported for TTR1 fibrils [207], (D-side) and (D-face) TTR1 fibrils formed at
pH 2 exhibited a flat tape-like morphology. (H) and (D) TTR1 fibrils (pH 2) showed
a width = 15.5± 3.8 nm (Average of 20 measurements). The (D-side) and (D-face)
TTR1 fibrils (pH 2) appeared to be formed of several protofilaments associated side-
by-side, had a width = 18.1± 5.4 nm (Average of 20 measurements), and are similar
to those previously reported by Jaroniec et al [77].
TEM of (D-side) TTR1 fibrils formed without pH adjustment (pH 3) (Figure 7.11(a))
indicated a twisted morphology with a width = 14.5± 1.8 nm (Average of 20 measure-
ments), similar to the widths previously reported for TTR1 fibrils [110, 207]. TEM
of (D-face) TTR1 fibrils formed without pH adjustment (pH 3) (Figure 7.11(b)) gave
similar morphology and dimensions to that of (D-side) TTR1 fibrils.
The TEM and X-ray fibre diffraction of TTR1 fibrils formed without pH adjustment
(pH 3) were consistent. TTR1 fibrils formed under these conditions were concluded to
give the same polymorph for each of the labelling schemes.
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(a) (b)
(c) (d)
Figure 7.10: TEM images of the four labelled TTR1 fibrils prepared at pH 2: (a)
(H) TTR1; (b) (D) TTR1; (c) (D-side) TTR1, (d) (D-face) TTR1. TTR1 fibrils were
formed at a concentration of 10 mg ml−1 at pH 3.0 in Milli-Q water, incubated at
room temperature for 72 h. TTR1 fibrils were freeze-thawed three times and diluted
to 0.1 mg ml−1 in Milli-Q water, an aliquot of the solution (5µL) was then deposited
on a copper grid for imaging.
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(a)
(b)
Figure 7.11: TEM images of (D-side) and (D-face) TTR1 fibrils prepared at pH 3
showing a twisted morphology: (a) (D-side) TTR1; (b) (D-face) TTR1. TTR1 fibrils
were formed at a concentration of 10 mg ml−1 at pH 3.0 in Milli-Q water, incubated at
room temperature for 72 h. TTR1 fibrils were freeze-thawed three times and diluted
to 0.1 mg ml−1 in Milli-Q water, an aliquot of the solution (5µL) was then deposited
on a copper grid for imaging.
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7.2.2 TTR1 Fibril Simulation Model
Two dummy unit cells representative of a section of the amyloid spine consisting of
two β-strands in each of the two β-sheets were constructed for H/D/D-side and D-
face TTR1 fibrils in the program VESTA [113]. Both unit cells had the following
parameters: Space group P1; a = 9.4A; b = 17.6A; c = 36.0A; and, α=β=γ = 90°.
These unit cell dimensions were chosen based on experimental XRD values (2 × 4.7A,
2 × 8.8A) and a previously reported unit cell for TTR1 fibrils (2 × 4.7A, 2 × 8.8A,
36A) [76]. The inter-strand repeat of the unit cell is 4.7A, and the inter-sheet repeat of
the unit cell is 8.8A. A unit cell consisting of two β-strands in each of the two β-sheets
was chosen to allow modelling of whether the strands within the sheets are parallel or
anti-parallel.
The H/D/D-side dummy unit cells are presented in Figure 7.12 and 7.14. Each β-strand
is represented by 18 atoms parallel to the c axis of the unit cell.
The D-face dummy unit cells are presented in Figure 7.13. Each β-strand is represented
by 2 × 18 atoms parallel to the c axis of the unit cell to distinguish between the two
faces of the β-strand.
The number and spacing of the ‘dummy atoms’ within a β-strand is arbitrary. We do
not expect insight into the features arising from this spacing. Features under investi-
gation occur at larger length-scales, such as the inter-sheet and inter-strand spacing.
Powder neutron diffraction patterns were generated using CrystalDiffract 6.7.3 and a
wavelength of 2.425A [114].
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(a)
(b)
Figure 7.12: The two simulated unit cell models arising from hydrogenated and
deuterated TTR1: (a) Hydrogenated; and, (b) Deuterated.
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Figure 7.13: The four simulated unit cell models arising from (D-face) TTR1: (a)
Face Model 1; (b) Face Model 2; (c) Face Model 3; and, (d) Face Model 4.
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Figure 7.14: The four simulated unit cell models arising from (D-side) TTR1: (a)
Side Model 1; (b) Side Model 2; (c) Side Model 3; and, (d) Side Model 4.
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7.2.3 Neutron Fibre Diffraction
The simulated 1D neutron diffraction patterns for (H), (D), (D-face) and (D-side)
TTR1 are shown in Figure 7.17, 7.20, 7.23 and 7.26, respectively. The corresponding
experimental 2D neutron diffraction patterns are shown in Figure 7.16, 7.18, 7.21 and
7.24, respectively.
Both experimental 2D patterns of (H) and (D) TTR fibrils gave characteristic signals
at 4.7A and ∼ 8-10A, representative of the cross-β structure which was also present
in the 1D simulated data.
The experimental 2D pattern of face-labelled TTR1 fibrils reveals an intense ring at
19.5A perpendicular to the 4.7A ring arising from the inter-strand spacing. A com-
parison of the experimental data (Figure 7.21) with the simulated data (Figure 7.23)
reveals that only Face Model 2 has a peak in the range (17.6A) that corresponds to the
19.5A ring of the experimental data. It can therefore be deduced that the β-strands
and β-sheets in the (D-face) TTR1 fibrils are arranged as shown in the Face Model
2 (Figure 7.4(b)). From the initial 15 zipper groups, the possible zipper group of the
TTR1 fibrils can be reduced to the zipper groups associated with the Face Model 2,
which are 1a, 1b, 3, 5a and 5b.
By determining a model for the (D-side) TTR1 fibrils and cross-checking the associated
zipper groups with those of Face Model 2 it may be possible to derive the zipper group
of TTR1 fibrils. The experimental 2D pattern of side-labelled TTR1 fibrils (7.24)
exhibits rings at 4.7A, 9.7A, 19.6A and 36A. A comparison of the experimental data
(Figure 7.24) with the simulated data (Figure 7.26) reveals that only Side Model 1 has
a peak at 36A.
In the case of the correct model for the (D-side) TTR1 fibrils being Side Model 1, the
associated zipper groups would be 2, 3 and 9. Cross-checking of Face Model 2 and
Side Model 1 would determine the zipper group to be zipper group 3. This would be
an interesting observation as zipper group 3 has not been commonly reported in the
literature.
A previous investigation by Fitzpatrick et al. into the atomic-resolution structure of
TTR1 fibrils combined structural restraints from magic angle spinning NMR spec-
troscopy, X-ray fibre diffraction, cryo-EM, STEM, and AFM [11]. The results deter-
mined the ‘packing’ of TTR1 fibrils to be of steric zipper group 4.
These results do not agree with the steric zipper groups determined by neutron fibre
diffraction. This discrepancy is interesting due to the results being drawn from different
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techniques. For the neutron fibre diffraction and modelling to give steric zipper group
4 as the result would require Face Model 1 to be correct for the (D-face) TTR1 fibrils
and Side Model 2 to be correct for (D-side) TTR1 fibrils. Further investigations are
required.
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Figure 7.15: (H) TTR1 2D neutron fibre diffraction.











































Figure 7.17: (H) TTR1 1D neutron diffraction simulation.
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Figure 7.18: (D) TTR1 2D neutron fibre diffraction.

















































Figure 7.20: (D) TTR1 1D neutron diffraction simulation.
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Figure 7.21: (D-face) TTR1 2D neutron fibre diffraction.














































Figure 7.23: (D-face) TTR1 1D neutron diffraction simulation.
119
TTR1 Neutron Fibre Diffraction 7.2. Results and Discussion

















Figure 7.24: (D-side) TTR1 2D neutron fibre diffraction.


















































Figure 7.26: (D-side) TTR1 1D neutron diffraction simulation.
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7.3 Conclusion
Firstly, we have shown for the first time the use of deuterium labelling for neutron fibre
diffraction of amyloid fibrils. Secondly, we have shown that neutron fibre diffraction
with a deuterium labelling scheme of a peptide could be used as a new way of obtaining
information on peptide packing to determine the zipper group of an amyloid fibril.
Currently, the data suggests that for the TTR1 fibrils formed in this experiment, their
structural packing is that of steric zipper group 3. Only Face Model 2 has a peak in
the region that corresponds to the experimental value of 19.5A for (D-face) TTR1 and
only Side Model 1 has a peak that matches the experimental peak at 36A for (D-side)
TTR1, cross-checking to give steric zipper 3.
Previously, elucidating information regarding the packing within amyloid fibrils re-
quired multiple labelling schemes containing several different isotopes. Jaroniec et al.
reported the molecular structure of TTR(105–115) fibrils using solid-state NMR, which
required at least several labelling schemes consisting of uniformly 13C, 15N (U-13C,
15N)-labelled peptides [76].
Here, with further refinement of the neutron fibre diffraction technique, the number of
labelling schemes could effectively be reduced to two (Face and Side), and would only
require the use of one isotope (Deuterium).
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Future Work and Overview
8.1 Lysozyme Elongation Kinetics and a Label-Free Assay
8.1.1 Lysozyme Elongation Kinetics
To determine if seeded HEWL aggregation switches elongation pathway when high
initial concentrations of monomer are used, a time-resolved SAXS experiment where
seeded HEWL aggregation is carried out under quiescent conditions could be per-
formed. The scattering curves from the seeded aggregation experiment using low initial
monomer concentration should be described by linear combinations of the scattering
from HEWL monomers and HEWL fibrils. The elongation pathway is predicted to be
monomer addition to fibrils and therefore the only components of significant concen-
tration expected in the solution are that of HEWL monomers and HEWL fibrils.
If there is a change in the elongation pathway from monomeric to oligomeric addi-
tion at higher initial monomer concentrations, then scattering curves from the seeded
aggregation experiment using high initial monomer concentration should not be ac-
curately described by linear combinations of the scattering from HEWL monomers
and HEWL fibrils. Instead, singular value decomposition analysis of the scattering
curves obtained during elongation should suggest the presence of three components:
monomers, oligomers and fibrils [208].
If there is depletion of the monomer component but the oligomer component is still
present and elongation of the fibrils is ongoing at later stages in the aggregation kinetics,
this would support an oligomer elongation pathway. Additionally, if there is an oligomer
component present and the amount of oligomers is proportional to the growth rate, then
this would further support an elongation pathway consisting of oligomer addition [208].
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8.1.2 Combined Small Angle X-ray Scattering and Wide Angle X-ray
Scattering Assay to Follow Lysozyme Aggregation
The recent development of a new beamline-compatible rheometer has potentially miti-
gated the issues which were encountered in this thesis. In future work the SAXS/WAXS
technique would be applied to follow the kinetics of other proteins and peptides. As
there is no label molecule present in this technique it may be useful to use this method
to investigate the effect inhibitor molecules have on aggregation kinetics. The absence
of any molecular labels ensures there are no off-pathway interactions occurring during
aggregation, that are caused by interaction of the label and the inhibitor.
Kurouski et al. reported that small differences in the pH of the aggregation solution for
lysozyme fibrils caused marked difference in the morphology of the fibrils [146]. They
reported that lysozyme fibrils formed at pH 1.0-1.5 had a flat tape-like morphology
whilst lysozyme fibrils formed at pH 2.7 had a left-twisted morphology. Using vibra-
tional circular dichroism, they were able to determine that lysozyme fibrils formed at
pH 2.3 were an almost equal mixture of the fibrils formed at pH 1.0-1.5 and pH 2.7. It
would be incredibly interesting to use the combined SAXS/WAXS/Rheo technique to
investigate the amyloid fibril growth kinetics of a solution containing monomer seeded
with two polymorphs of equal concentration. It would allow further insight into poly-
morph behaviour and why certain polymorphs may be favoured.
Berryman et al. reported that amyloid fibrils with antiparallel symmetries in general
are more structurally stable than amyloid fibrils with parallel symmetries due to the
ability to form more backbone hydrogen bonds [209]. If the lysozyme fibrils formed at
pH 2.3 were a mixture of fibrils with antiparallel symmetries and fibrils with parallel
symmetries, and were investigated using the SAXS/WAXS/Rheo technique then at the
beginning of the experiment both the SAXS and WAXS patterns would be a mixture
of the two polymorphs. However, the shearing of the solution would lead to greater
breakage of the fibrils with parallel symmetries due to their lower structural stability.
There would then be a greater amount of seeds for one of the polymorphs leading to
a greater overall aggregation rate for that polymorph, the rate of which would amplify
over the course of aggregation. Eventually, the SAXS and WAXS patterns would be
dominated by the signal from the less structurally stable fibrils.
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8.2 NFGAIL Linear Elongation SANS
Due to perdeuterated TTR being demonstrated to aggregate at a different rate to
hydrogenated TTR, in future experiments it would be pertinent to investigate the effect
that deuteration has on the aggregation of amyloid fibrils [71]. Experiments probing the
aggregation of hydrogenated seeds and hydrogenated monomer, hydrogenated seeds and
deuterated monomer, deuterated seeds and hydrogenated monomer, and deuterated
seeds and deuterated monomer would allow insight into whether deuteration of the
peptide or protein affects the rate of aggregation. Further to this, investigating whether
the D2O % of the solution affects the rate of aggregation would also be important [210].
Currently, some of the conclusions drawn from these results are based on the assumption
that amyloid fibril growth is bidirectional and these results would change if the growth
was unidirectional. Future work on whether this assumption is correct would validate
these conclusions and also shed further light on a widely debated topic of amyloid fibrils
[172, 174, 179, 211–214]. Interestingly, for Sup35p, a yeast prion determinant, both
unidirectional and bidirectional elongation has been reported using different techniques
[215, 216]. For these techniques there appears to be a possibility that when amyloid
growth is observed in-situ on a surface, interactions between the fibrils and the surface
could affect fibril growth [217]. For these techniques the possible influence of the surface
on the growth kinetics cannot be ruled out.
The contrast matching SANS technique demonstrated in this thesis could also be used
to investigate whether amyloid fibril growth is unidirectional or bidirectional. As it is
a bulk technique in solution, surface interactions affecting the growth can be ruled out.
This technique would consist of first generating hydrogenated fibril seeds that are short
enough that their lengths are detectable by SANS, then once the length of the seeds
had been measured by SANS, an equal concentration of deuterated monomer would
be added. Once elongation of the seeds by the deuterated monomer had finished, the
solution would be contrast matched and the contribution from the deuterated ends
would be measured. As the seed concentration is known, the seed lengths have been
measured and an equal concentration of deuterated monomer has been added, then for
unidirectional growth we would expect the length of the deuterated ends to be same as
the length of the seeds (Figure 8.1) and for bidirectional growth we would expect the
length of the deuterated ends to be half the length of the seeds (Figure 8.2).
If these experiments were to be repeated, they would benefit from further characteri-
sation of the deuterated fibrils and an investigation into the effect of temperature on
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x x
Figure 8.1: Schematic of Unidirectional Growth.
1⁄2 x x 1⁄2 x
Figure 8.2: Schematic of Bidirectional Growth.
the elongation rate. Repeating of the experiment with other peptides would also be of
great interest.
8.3 α-Synuclein Linear Elongation SANS
As in the NFGAIL experiments, experiments probing the aggregation of hydrogenated
seeds and hydrogenated monomer, hydrogenated seeds and deuterated monomer, deuter-
ated seeds and hydrogenated monomer, and deuterated seeds and deuterated monomer
would allow insight into whether deuteration of the peptide or protein affects the rate
of aggregation. Also, investigating whether the D2O % of the solution affects the rate
of aggregation would also be important [210].
The technique described in the previous section (8.2) to determine if fibril growth is
unidirectional or bidirectional could also be applied to α-synuclein and other proteins.
If these experiments were to be repeated, they would benefit from an investigation
into the effect of temperature and concentration on the elongation rate. Repeating
of the experiment with other proteins would also be of great interest. Measuring the
elongation rate of proteins that have a previously reported elongation rate would allow
comparison and verification of this technique. Also, investigating elongation rates of
α-synuclein polymorphs could help elucidate polymorphism behaviour.
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8.4 TTR1 Neutron Fibre Diffraction
Currently, the signal from the TTR1 fibrils is low when compared to the background
making it hard to discern reflections from the background. Future experiments would
benefit from increasing the amount of sample in the path of the beam. This would
increase the signal leading to improved signal-to-noise. There is also a possibility that
at the current concentration, the background noise is masking some of the reflections,
by increasing the concentration it may be possible to detect more reflections as the
weaker reflections become distinguishable from the background.
Unfortunately, due to instrumental constraints and limited availability of instrument
time there were aspects of the experiment that we were unable to perform but would
be of interest if there was more instrument time available or the experiments were
repeated. In the current experiment samples were prepared without any attempt at
preferential alignment and were measured at one position (χ = 90°). By inducing
preferential alignment in the samples and measuring at various positions, such as χ =
90° or 180°, it would be possible to obtain further information about the packing as
the alignment of the signal in relation to the alignment of the sample would reveal the
orientation of the reflections in the amyloid spine.
The reflection at 36A relating to the length of the peptide is almost obscured by
the beamstop. Unfortunately, the instrument did not have a smaller beamstop which
limited the range we could investigate and for longer peptides in the future it may be
necessary to use SANS to determine the peptide length in the steric zipper.
The current unit cell model and neutron powder diffraction simulations are simple
and would benefit from further development and refinement. An improvement on the
current model would be to develop it from a powder diffraction simulation to a fibre
diffraction simulation, taking into account the fibre axis direction and angular fibre
disorder and outputting a simulated 2D pattern [218]. The 2D simulated neutron fibre
diffraction pattern could then be compared side-by-side with the observed pattern.
Lastly, investigating other well characterised peptides with a known packing system
would allow further refinement and validation of the technique. It would be of great
interest to use this technique on polymorphs of a chosen peptide to probe the differences
in the packing of the fibril and in future work possibly postulate the various steric
zippers that a fibril forming peptide may form.
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8.5 Overview
In summary, several new techniques which allow the probing of a multitude of struc-
tural and kinetic parameters for amyloid fibrils have been shown. Firstly, a combined
SAXS/WAXS technique was demonstrated which could be used as a label-free assay
to follow amyloid aggregation whilst also allowing the simultaneous probing of fibril
morphology and structure in real time. The key advantage of this technique is that it
does not require an extrinsic label. With the absence of an extrinsic label the experi-
mental conditions can better mimic physiological conditions found in vivo. An extrinsic
label may alter the aggregation process and may only work under certain conditions
[134, 143–145]. This is especially significant when wanting to measure the effectiveness
of potential inhibitor molecules that could prevent aggregation. Inhibitor molecules
could quench the fluorescence of the label giving false positives or the label could pre-
vent the mechanism of the inhibitor molecule [137, 140, 151]. This new technique
would prevent those problems whilst also giving further insight from the simultaneous
structure probing. Analysis of the structures in solution during amyloid kinetics in
the presence of an inhibitor may allow a greater understanding of the mechanisms of
inhibition [7].
Secondly, a contrast-matched, isotope-labelled SANS experiment was shown to deter-
mine the elongation rate for both peptide and protein-based fibrils. In addition, this
approach was shown as a bulk method to investigate fibril number concentration, and
average seed length. Whilst measuring elongation was the focus of these experiments,
the technique also can test for the presence of secondary pathways and could easily be
used to determine if fibril elongation for a given peptide or protein was unidirectional
or bidirectional. This new technique provides a multitude of structural and kinetic
parameters in bulk solution without perturbation of the fibrils by extensive prepa-
ration procedures that are required for other techniques. The information obtained
from this technique allows an improved understanding of amyloid and prion diseases,
whilst also furthering the foundation of the theoretical understanding of peptide and
protein fibrillisation kinetics based on molecular models. An increased understanding
of the mechanisms behind the fibrillation process is essential in the development of
therapeutic approaches for the treatment of amyloid diseases [35].
Finally, a neutron fibre diffraction technique was demonstrated which provided infor-
mation on the packing within amyloid fibrils. This new technique yielded a simpler
labelling scheme than current solid state NMR techniques that investigate fibrillar
structure [77]. Understanding the relationship between amyloid structure and toxicity
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